U.S. patent application number 14/280093 was filed with the patent office on 2014-09-04 for intravenous fluid monitoring.
The applicant listed for this patent is James W. BENNETT, Leonid F. MATSIEV. Invention is credited to James W. BENNETT, Leonid F. MATSIEV.
Application Number | 20140249503 14/280093 |
Document ID | / |
Family ID | 40627050 |
Filed Date | 2014-09-04 |
United States Patent
Application |
20140249503 |
Kind Code |
A1 |
BENNETT; James W. ; et
al. |
September 4, 2014 |
INTRAVENOUS FLUID MONITORING
Abstract
Apparatus, systems and methods related to monitoring intravenous
fluids during administration to a subject are disclosed. These
apparatus, systems and methods provide near real-time monitoring of
the identity of one or more components of an intravenous fluid.
Inventors: |
BENNETT; James W.; (Santa
Clara, CA) ; MATSIEV; Leonid F.; (San Jose,
CA) |
|
Applicant: |
Name |
City |
State |
Country |
Type |
BENNETT; James W.
MATSIEV; Leonid F. |
Santa Clara
San Jose |
CA
CA |
US
US |
|
|
Family ID: |
40627050 |
Appl. No.: |
14/280093 |
Filed: |
May 16, 2014 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
12920203 |
Aug 30, 2010 |
8728025 |
|
|
PCT/US2009/001494 |
Mar 9, 2009 |
|
|
|
14280093 |
|
|
|
|
61035339 |
Mar 10, 2008 |
|
|
|
61049367 |
Apr 30, 2008 |
|
|
|
61198523 |
Nov 6, 2008 |
|
|
|
Current U.S.
Class: |
604/506 ;
73/61.48 |
Current CPC
Class: |
A61M 2205/33 20130101;
A61M 2205/3317 20130101; G16H 20/17 20180101; A61M 2209/02
20130101; A61M 5/16827 20130101; G01N 27/026 20130101; G01N 27/02
20130101; A61M 5/168 20130101; G01N 21/17 20130101; A61M 2205/3313
20130101; A61M 2205/3375 20130101; A61M 2205/331 20130101 |
Class at
Publication: |
604/506 ;
73/61.48 |
International
Class: |
A61M 5/168 20060101
A61M005/168; G01N 27/02 20060101 G01N027/02; G01N 21/17 20060101
G01N021/17 |
Claims
1. A method for determining the composition of an intravenous
fluid, the method comprising: contacting a first pair of electrodes
of a device for multi-parametric testing of intravenous fluid with
an intravenous fluid; optically examining the intravenous fluid
with an optical sensor to determine an optical property of the
intravenous fluid; determining a multi-parametric profile from the
intravenous fluid, wherein the multi-parametric profile comprises a
first parameter comprising a complex admittance or impedance signal
from the intravenous fluid, and a second parameter comprising the
optical property of the intravenous fluid; comparing the
multi-parametric profile to stored expected parameter values to
determine the identity and concentration of one or more components
of the intravenous fluid.
2. The method of claim 1, wherein comparing the multi-parametric
profile comprises simultaneously determining the concentration and
identity of one or more components of the intravenous fluid.
3. The method of claim 1, wherein the first parameter comprises an
electrical admittance or impedance measurement taken at a plurality
of frequencies.
4. The method of claim 1, wherein optically examining comprises
optically examining the intravenous fluid with one or more of: an
optical transmission sensor, an absorbance sensor, a spectrometer;
a colorimeter, or a turbidity sensor.
5. The method of claim 1, wherein determining a multi-parametric
profile from the intravenous fluid further comprises determining a
third parameter comprising a second complex admittance or impedance
signal from the intravenous fluid.
6. The method of claim 1, wherein comparing the multi-parametric
profile to stored expected parameter values to determine the
identity and concentration of one or more components of the
intravenous fluid comprises simultaneously determining both the
identity and the concentration of one or more components of the
intravenous fluid.
7. The method of claim 1, wherein comparing the multi-parametric
profile to stored expected parameter values to determine the
identity and concentration of one or more components of the
intravenous fluid comprises determining the identity and
concentration of all of the components of the intravenous
fluid.
8. The method of claim 1, further comprising connecting the testing
device to an intravenous infusion device for infusion of fluid into
the vascular system of a patient.
9. A multi-parametric intravenous fluid monitoring apparatus for
determining the composition of an intravenous fluid, the apparatus
comprising: a substrate adapted for fluidic interface with source
of intravenous fluid prepared for delivery into a patient; a first
sensor element on the substrate comprising a pair of electrodes
configured to measure the complex admittance or impedance of the
intravenous fluid; a second sensor element comprising an optical
sensor; and a processor configured to receive data from the first
sensor element and the second sensor element, wherein the processor
comprises a comparator configured to compare parameters derived
from the first and second sensor element with stored expected
parameter values to determine the identity and the concentration of
one or more components of the intravenous fluid.
10. The apparatus of claim 9, wherein the optical element comprises
one of: a transmission sensor, an absorbance sensor, a
spectrometer; a colorimeter, or a turbidity sensor
11. The apparatus of claim 9, wherein the first sensor element
comprises an electrical admittance or impedance sensor configured
to determine the complex admittance or impedance over a range of
frequencies.
12. The apparatus of claim 9, further comprising a third sensor
element on the substrate comprising a pair of electrodes configured
to measure the complex admittance or impedance of the intravenous
fluid.
13. The apparatus of claim 9, wherein the processor comprises
stored expected parameter values able to uniquely identify one or
more pharmaceuticals in a carrier solution, wherein the carrier
solution comprises one of: D5W, 3.3% Dextrose/0.3% saline,
Half-normal saline, Normal saline, and Ringers lactate, and the one
or more pharmaceuticals comprises one or more of: an anticoagulant,
a metabolically-active hormone, an anticoagulant, and an
analgesic.
14. The apparatus of claim 9, wherein the first sensor element
comprises a third electrode.
15. The apparatus of claim 9, wherein the substrate is within a
housing comprising one or more conduits and having a first end
adapted for fluid communication with the fluid source and a second
end adapted for fluid communication with an intravenous infusion
device for infusion of fluid into the vascular system of the
patient.
Description
CROSS REFERENCE TO RELATED APPLICATIONS
[0001] This application is a continuation of U.S. patent
application Ser. No. 12/920,203, filed Aug. 30, 2010, titled
"INTRAVENOUS FLUID MONITORING," Publication No. US-2011-0009817-A1,
which is 35 U.S.C. .sctn.371 National Phase Application of
International Patent Application No. PCT/US2009/001494, filed Mar.
9, 2009, titled "INTRAVENOUS FLUID MONITORING," Publication No. WO
2009/114115 A1, which claims the benefit of U.S. Provisional Patent
Application Nos.: 61/035,339, filed Mar. 10, 2008; 61/049,367 filed
Apr. 30, 2008 and 61/198,523 filed Nov. 6, 2008, each of which is
herein incorporated by reference in its entirety.
INCORPORATION BY REFERENCE
[0002] All publications and patent applications mentioned in this
specification are herein incorporated by reference in their
entirety to the same extent as if each individual publication or
patent application was specifically and individually indicated to
be incorporated by reference.
BACKGROUND
[0003] The invention relates to intravenous fluid monitoring
apparatus, systems and methods. In particular, the invention
relates to intravenous fluid monitoring apparatus and systems
comprising sensors for identifying one or more components of an
intravenous fluid, and to methods for intravenous delivery of fluid
to a subject including sensing of the fluid during administration
to the subject.
[0004] Intravenous fluid delivery systems and methods are known in
the art. Such systems can generally comprise an intravenous
infusion device (e.g, such as a cannula or a catheter) for infusion
of fluid into the vasculature system of a subject in need thereof
(e.g., a patient), one or more fluid sources for containing an
intravenous fluid or a component thereof, and an fluid line
assembly providing fluid communication between the one or more
fluid sources and the intravenous infusion device. Known systems
include multiple arrangements and configurations, including,
generally for example various systems (e.g., gravity-feed systems;
pump systems) for providing a motive force for delivery of the
fluid from the source to the subject, as well as various further
components typically integrated into the fluid line assembly such
as conduits, fittings (e.g., Luer Lock.TM. fittings), backflow
blocks, valves, and injection ports.
[0005] Some intravenous fluid delivery systems known in the art
also include one or more sensors, such as flow sensors (to measure
a precise amount of a fluid being delivered), pressure sensors
(e.g., to detect fluid line blockage) and/or ultrasonic sensors
(e.g., to detect air-bubbles). See, for example, U.S. Patent
Application No. US 2003/0159741 to Sparks.
[0006] Notwithstanding the various advances known in the art in
connection with intravenous fluid delivery, there remains a need in
the art for improvements, especially improvements which enhance the
accuracy and/or reliability of treatments involving intravenous
fluid delivery to patients, and correspondingly which enhance
patient safety. In particular, there remains a need for
improvements in sensing, monitoring and recording the identity of
fluid compositions (e.g, component identity, component
concentration, component dose (e.g, current, projected) etc.) being
delivered to patients in the course of treatment.
SUMMARY OF THE DISCLOSURE
[0007] The present inventions provide apparatus, systems and
methods related to intravenous fluid administration. The apparatus,
systems and methods of the invention are more specifically related
to monitoring of intravenous fluids during administration to a
subject. As described herein and in further detail below, the
various inventions offer intravenous fluid monitoring approaches
which are significantly advantaged over known systems, including
for example by providing near real-time monitoring of the identity
of one or more components of an intravenous fluid (e.g., the
presence or absence of a component, the composition of a component,
the concentration of a component, the time (absolute time or
relative time versus other components) of infusion of a component,
the onset of component infusion (i.e., delivery through an infusion
device); the completion of component infusion, the component dosing
level (e.g, cumulative dosing level--current or projected), etc.).
Such near real-time monitoring of intravenous fluids reduces the
potential for errors associated with intravenous administration,
and especially intravenous drug administration. Hence, the
apparatus, systems and methods of the invention provide substantial
advances in patient safety. Such advances in safety can translate
to a more meaningful patient treatment experience, and to enhanced
operational efficiencies and reduced expenses for hospitals and
other entities which administer fluids intravenously. Such
inventions can applied, and such advantages can be realized in a
number of various settings and applications in which intravenous
fluids are administered, including for example, without limitation,
at hospitals, clinics, surgical centers, homes (e.g., home
hospice), nursing homes, assisted living environments, etc.
[0008] Generally, the apparatus, systems and methods of the
invention are directed to or effective for identifying one or more
components of an intravenous fluid during administration of the
fluid to a subject. Preferably, the apparatus, systems and methods
of the invention are directed to or effective for identifying one
or more active pharmaceutical agents within an intravenous fluid
during administration of the fluid to a subject. Such active
pharmaceutical agents can include, for example, an anticoagulant
(e.g., heparin), a metabolically-active hormone (e.g, insulin), an
anesthetic (e.g., propofol), and/or an analgesic (e.g., morphine),
among others. Additionally or alternatively, the apparatus, systems
and methods of the invention are directed to or effective for
identifying one or more other components of an intravenous fluid,
preferably components used for hydration and ion metastasis of
subjects. Such components can preferably include, for example one
or more components selected from potassium chloride, sodium
chloride, Ringer's lactate, and dextrose, in each case in molecular
or ionic (e.g, dissociated) form (e.g, sodium ion, potassium ion,
chloride ion, calcium ion, lactate ion, and dextrose).
[0009] Generally, and preferably, the apparatus, systems and
methods of the invention are directed to or effective for
identifying one or more components of an intravenous fluid during
administration of the fluid to a subject using a multi-parametric
approach. In such approach, multiple parameters (e.g, multiple
fluid properties such as without limitation refractive index,
electrochemical potential, impedance, admittance, conductivity,
etc.) can be sensed, and the combination of parameters can be
correlated to obtain resolution of components within the fluid.
Hence, an intravenous fluid can be sensed--for example with
multiple sensors (or with a sensor having multiple sensor elements)
and/or with multiplexing of a sensor element to obtain independent
sensing measurements--to generate a multi-parametric profile
characteristic of component identity within the fluid. A
multi-parametric profile can be correlated to determine an identity
of one or more components of the fluid. Such multi-parametric
approaches advantageously provide for improved resolution of
components; therefore such approaches allow for improved ability to
distinguish between different fluid compositions, including for
example the presence or absence of particular active
pharmaceuticals, and/or various concentrations of a particular
active pharmaceutical or other component. Multi-parametric
approaches as described herein are preferred, an can be generally
used with any aspects, embodiments and approaches described herein;
however, many aspects, embodiments and approaches of the invention
do not require multi-parametric approaches and can be effected
independently thereof.
[0010] Generally, and preferably, the apparatus, systems and
methods of the invention are directed to or effective for
identifying one or more components of an intravenous fluid during
administration of the fluid to a subject using one or more sensors.
The one or more sensors are preferably selected to include at least
one sensor other than a flow sensor, and/or in some embodiments
also preferably other than a pressure sensor, and/or in some
embodiments also preferably other than an ultrasonic sensor.
Generally for example, preferred sensors effective with the
apparatus, systems and methods of the invention can include,
without limitation, one or more sensors selected from an impedance
sensor (e.g, an AC impedance spectroscopy sensor), an
electrochemical sensor (e.g., an electrochemical potential sensor),
a thermal sensor (e.g., a thermal anemometer sensor), an optical
sensor (e.g., a refractometer sensor, a transmission sensor, an
absorbance sensor, a spectrometer (including a colorimeter) or, a
turbidity sensor), a rheological sensor (e.g., a viscometer), an
electrical property sensor (e.g., a capacitor sensor, a pH sensor,
a conductivity sensor, and an inductive sensor), and a
fluid-displacing and/or fluid-shearing (e.g, resonator) sensor. In
various preferred embodiments, the sensors can be one or more
sensors selected from an impedance sensor (e.g, an AC impedance
spectroscopy sensor) and an optical sensor (e.g., a refractometry
sensor, a transmission sensor, an absorbance sensor, a spectrometer
(including a colorimeter) or, a turbidity sensor). In certain
preferred embodiments, the apparatus, systems and methods of the
invention comprise or use at least two or more sensors or an
integrated assembly comprising two or more sensors (e.g., an
integrated assembly comprising two or more sensor elements, each
sensor element comprising one or more sensing surfaces), and
preferably such two or more sensors being of different types and/or
having different sensor approaches (e.g., impedance sensor,
electrical property sensor, optical sensor, etc.). Preferably, such
two or more sensors can include an impedance sensor (e.g, an AC
impedance spectroscopy sensor), a thermal sensor, and/or an optical
sensor (e.g., a refractometry sensor, a transmission sensor, an
absorbance sensor, a spectrometer (including a colorimeter) or, a
turbidity sensor). Preferably, such two or more sensors can be
integrated into a common assembly, such as a common substrate,
e.g., as part of a common sensor subunit. For example, the
apparatus, systems and methods of the invention comprise an
impedance sensor (e.g, an AC impedance spectroscopy sensor) and an
optical sensor (e.g., a refractometry sensor), each integral with
and/or in a common sensor assembly such as a common substrate, or a
common sensor subunit. The various specific sensors and sensing
approaches as described herein are preferred, an can be generally
used with any aspects, embodiments and approaches described herein;
however, many aspects, embodiments and approaches of the invention
do not require such certain specific sensors or sensing techniques
and can be effected independently thereof.
[0011] Generally, and preferably, the apparatus, systems and
methods of the invention are directed to or effective for
identifying one or more components of an intravenous fluid during
administration of the fluid to a subject using a sensor having a
sensor element (e.g., with a sensing surface adapted for
interaction with and being responsive to the intravenous fluid),
where such sensor element (e.g., such sensing surface) is
positioned at a location within an intravenous fluid system such
that it interacts with the fluid (e.g, such sensing surface
contacts the fluid) in relative proximity to the infusion
location--the location at which the fluid enters a subject's
vasculature system. Advantageously, monitoring of intravenous
fluids proximal to the infusion location (e.g, proximal to the
distal end of a fluid line assembly of an intravenous fluid
delivery system, and/or proximal to an infusion device of an
intravenous fluid delivery system) can effectively reduce the
potential for errors associated with intravenous administration.
Such proximity is less constrained by physical distance; rather it
more generally refers to a location within an intravenous fluid
delivery system at which the composition of the intravenous fluid
is representative of (if not identical to) that which is delivered
to the subject. Hence, such proximity typically refers to a
position or location within the intravenous fluid delivery system
which is downstream relative to various components of the
intravenous fluid delivery system which could change or otherwise
effect the fluid identity (e.g., composition, concentration etc.),
including for example downstream of infusion valves, injection
ports, supply line junctions, etc. In various embodiments of
various aspects of the invention, therefore, the apparatus, systems
and methods of the invention comprise a sensor element (e.g.,
having a sensor surface) positioned proximal to (e.g, at or near)
the distal end of a fluid line assembly, and/or proximal to an
infusion device. For example, such a sensor element can include a
sensing surface in a cavity of an in-line housing, where the
in-line housing optionally has inlet and outlet fittings (e.g.,
luer locks), and can be integrated into the fluid line assembly
upstream of an infusion device. Alternatively, for example, such a
sensor element can include a sensing surface in a cavity of a
housing defined in infusion device (e.g., catheter, needle, etc.).
Further, in some embodiments, in addition to one or more sensors
positioned for monitoring of intravenous fluids proximal to the
infusion location (e.g, proximal to the distal end of a fluid line
assembly and/or proximal to an infusion device), the apparatus,
systems and method of the invention can also include an additional
sensor positioned upstream of an injection port--facilitating for
example a differential measurement approach. The approaches for
positioning of the sensor element proximal to the infusion
location, as described and as variously exemplified herein are
preferred, and can be generally used with any aspects, embodiments
and approaches described herein; however, many aspects, embodiments
and approaches of the invention do not require such certain
specific positioning approaches and can be effected independently
thereof.
[0012] Generally, and preferably, the apparatus, systems and
methods of the invention are directed to or effective for
identifying one or more components of an intravenous fluid during
administration of the fluid to a subject (e.g., a specific patient,
for example at a hospital, clinic, surgical environment, home
hospice, nursing home, assisted living environment, etc.), where
such subject is positively and specifically identified in
connection with monitoring and administration of the intravenous
fluid. Various embodiments and aspects of the invention can include
approaches for correlating the sensor data (i.e., data (e.g., as
represented by a signal) originating from the sensor--either raw
data or more typically processed data) to a specific subject (e.g.,
patient). For example, the sensor (or apparatus or system
comprising a sensor) can include an identifier circuit for
correlating sensor data to a specific subject. Typically, and
preferably, such identifier circuit may be in communication with
one or more other circuits, including for example circuits for
receiving, processing, storing, displaying or transmitting data,
including data originating from the sensor element, such as a
signal processing circuit or a data retrieval circuit. Such
integrated patient-identification approaches can further enhance
the benefit to patient safety, by reducing the potential for errors
associated with intravenous administration, and especially
intravenous drug administration. The various subject-identifier
approaches as described herein are preferred, an can be generally
used with any aspects, embodiments and approaches described herein;
however, many aspects, embodiments and approaches of the invention
do not require such certain specific subject-identifier approaches
and can be effected independently thereof.
[0013] Generally, and preferably, the apparatus, systems and
methods of the invention are directed to or effective for
identifying one or more components of an intravenous fluid during
administration of the fluid to a subject with a remote and/or
centralized monitoring approach. Although such remote and/or
centralized monitoring approaches can be effected for an individual
subject (e.g, in a home hospice environment), such approaches are
especially advantageous in connection with multi-subject care
environments. For example, different sensor data from one subject
or from several different subjects (in each case, such sensor data
being locally generated and specifically associated with an
intravenous fluid being administered to a particular subject) can
be acquired and/or monitored at a location which is remote
(relative to the patient)--such as a nursing station; preferably
such sensor data can be centrally monitored at such remote
location. In various aspects and embodiments therefore, sensor data
can be generated in a processor local to and in communication with
a sensor element (e.g., having a sensing element in contact with
the intravenous fluid), preferably for each of two or more
subjects, and then such locally-generated sensor data stream(s) can
be acquired by a processor remote from the sensor element. Such
acquisition can be effected, for example, via wireless (e.g., WiFi,
Bluetooth.RTM., WiMax, IR, RF) or other communication approaches.
The remote processor can comprise one or more circuits for
receiving, processing, storing, displaying or transmitting the
acquired sensor data. The acquired sensor data can be monitored
remotely, including for example at a central monitoring location.
Preferably for example, the monitoring can be done visually by
human interaction with a display and/or can be further enhanced and
effected by various automated approaches. In one such automated
monitoring approach, a monitoring circuit can comprise a data
comparator module for comparing one or more parameters (e.g, data
values) derived from sensor data with one or more parameters (e.g.,
data values) which are prescribed or proscribed for a particular
subject (e.g. patient). Such patient-relevant parameters can be
treatment-centric (e.g., applicable to all such patients undergoing
a particular treatment), including semi-customized
treatment-centric parameters which include a patient-specific data
input (e.g., a patient weight, patient age, etc.) to determine a
treatment-centric parameter, and/or such patient-relevant
parameters can be patient-centric (e.g., wholly customized for a
specific patient). Exemplary non-limiting parameters can include
dosing levels, dosing timing (onset or completion), dosing
frequency, etc. for various and specific active pharmaceutical
agents or other components of an intravenous fluid.
Patient-relevant parameters can be specific for the intravenous
monitoring system effected by the apparatus, systems and methods of
the invention, and/or can be common with (e.g., shared with)
various other systems, such as infusion pump systems (e.g., "smart
pumps"). In one embodiment, such infusion pump includes a control
system with a data input module, whereby patient-specific data
(e.g, weight) can be used to determine a patient relevant parameter
used by both the pump controller (as known in the art) and/or for
use by the monitoring circuit, e.g. a comparator module, of the
present inventions for comparison to a sensor-data parameter. In
some embodiments, the monitoring circuit can share common circuitry
with (or have the same or similar functionality and/or software as)
a portion of the pump controller circuit. Advantageously, the
monitoring approaches of the apparatus, systems and methods of the
invention can also include certain notice (e.g., alarm)
features--to provide notice to a caregiver that a specific
patient's intravenous fluid delivery system is operating
incongruous with a prescribed or proscribed treatment, and/or can
also include certain corrective action (e.g., system control)
features--to make, preferably automated, a corrective action with
the intravenous fluid delivery system. For example, upon
determining an inconsistency between corresponding
sensor-data-derived parameter and prescribed or proscribed
patient-relevant parameter, an alarm can sound and/or a control
circuit can activate a control element (e.g., an automated infusion
valve) to make a change in the intravenous administration regime.
Such remote and/or central monitoring approaches can further
enhance the benefit to patient safety, by reducing the potential
for errors associated with intravenous administration, and
especially intravenous drug administration. The various remote
and/or central monitoring approaches as described herein are
preferred, an can be generally used with any aspects, embodiments
and approaches described herein; however, many aspects, embodiments
and approaches of the invention do not require such remote and/or
central monitoring approaches and can be effected independently
thereof.
[0014] Generally, and preferably, the apparatus, systems and
methods of the invention are directed to or effective for
identifying one or more components of an intravenous fluid during
administration of the fluid to a subject with a sensor that
comprises a processor (e.g, as included within a processor
assembly) which is physically separable from, and intermittently
interfaceable with (e.g., for a finite, operationally effective
period of time) a sensor element (e.g., as included within a
housing assembly). The approach of a temporally-limited engagement
(interfacement) of the processor and the sensor element allows for
regular operation while engaged/interfaced, and allows for physical
separation of sensing function and processing function of a sensor
(at least for some period of time) after or between operations,
with a corresponding separation of physical treatment of the
embodiments which effect such function. For example, the sensor
element can be physically separated from the processor for a period
of time to allow for sterilizing the sensor element (or a sensing
surface thereof) or for disposal and replacement of a
(pre-)sterilized sensor element (or a sensing surface thereof).
Such separation also allows for re-use of the processor--for
example, in connection with a second subsequent subject.
Significantly, since processors are generally more expensive than
sensor elements (or sensing surfaces thereof), the re-use of
processors in such a temporally-limited engagement (interfacing)
approach provides for efficiency of capital investment, especially
in a multi-subject (e.g., hospital, surgical, nursing care, etc.)
environment. The various approaches for
temporally-limited/intermittent engagement/interfacing of processor
and sensor element as described herein are preferred, an can be
generally used with any aspects, embodiments and approaches
described herein; however, many aspects, embodiments and approaches
of the invention do not require such approaches for
temporally-limited/intermittent engagement/interfacing of processor
and sensor element, and can be effected independently thereof.
[0015] Generally, and preferably, the apparatus, systems and
methods of the invention are directed to or effective for
identifying one or more components of an intravenous fluid during
administration of the fluid to a subject with a sensor that
comprises (i) an assembly comprising one or more sensor elements,
(ii) a signal-conditioning processor, including one or more
circuits adapted for conditioning (e.g, amplifying) a signal, and
(iii) a signal-identification processor, including one or more
circuits adapted for identifying or determining a signal
representative of the identity of one or more components of an
intravenous fluid (e.g. as corresponding to a component within a
composition or concentration of a component within a composition).
In one such preferred subembodiment, each of the assembly
comprising the one or more sensor elements, the signal-conditioning
processor, and the signal-identification processor are each
physically separate components. In an alternative of such preferred
subembodiment, the assembly comprising the one or more sensor
elements is physically separate from an integrated assembly
comprising the signal-conditioning processor and the
signal-identification processor. In another such preferred
subembodiment, an integrated assembly comprises each of the one or
more sensor elements, the signal-conditioning processor, and the
signal-identification processor. Such various approaches for
configuring the sensor elements, the signal-conditioning processor
and the signal-identification processor are preferred, an can be
generally used with any aspects, embodiments and approaches
described herein; however, many aspects, embodiments and approaches
of the invention do not require such approaches for configuring
these sensor components, and can be effected independently
thereof.
[0016] Various further aspects, embodiments and features of the
inventions are described herein throughout the specification and
drawings; the aforementioned general summary is intended to be an
introductory and non-limiting summary of several commercially
meaningful approaches included separately and in combination in
various inventions. Generally, these various inventions enhance the
accuracy and/or reliability of treatments involving intravenous
administration, thereby reducing risk of error in connection with
such treatments, and improving patient safety. The various
inventions also enable improved effectiveness and efficiency of
operations and improved efficiency of capital investment,
especially in a multi-subject environment. The following more
detailed summary, and the subsequent detailed description and
examples further describe the inventions.
[0017] In particular, in a first aspect, the invention is directed
to apparatus comprising a sensor (or a sensor subassembly) for
identifying one or more components of an intravenous fluid. In
general, in this first aspect of the invention the apparatus
comprises one or more sensor elements having a sensing surface
responsive to a fluid (e.g., to a fluid property or a fluid
composition). Preferably, the sensing surface of a sensor element
is positioned for contact with the intravenous fluid.
Alternatively, however, the sensing surface of a sensor element can
be positioned for indirect, non-contact sensing of a fluid.
Preferably, the sensing surface of a sensor element is positioned
for contact with the intravenous fluid during the administration of
the fluid to the subject.
[0018] In a first general embodiment of the first aspect of the
invention, the invention is directed to an apparatus effective for
multi-parametric characterization of one or more fluid components.
Preferably, in this first general embodiment, the apparatus
comprises two or more sensor elements, each sensor element having a
sensing surface positioned for contact with the fluid. Preferably,
in this first general embodiments, the two or more sensor elements
can have a surface positioned in one or more cavities of a housing.
The housing can be adapted for fluidic interface with a fluid line
assembly of an intravenous fluid delivery system. For example, the
housing can be adapted for in-line fluid communication with the
fluid line assembly. Alternatively, the housing can be defined or
included in an intravenous infusion device (e.g., a catheter). The
two or more sensor elements can be independent of each other,
including for example having physically separate sensing surfaces,
and/or for example having sensing surfaces which are independently
addressable (e.g., independently activated, independently sampled,
including for example simultaneously using differentially
resolvable (deconvolutable) approaches or at different times). In
preferred subembodiments of this first general embodiment, the
apparatus can comprise one or more signal processing circuits for
(preferably independently) processing data originating from each of
the two or more sensor elements, the processing circuits being
configured to generate a multi-parametric profile characteristic of
a component of the fluid.
[0019] In a second general embodiment of the first aspect of the
invention, the invention is directed to an apparatus effective for
deploying sensor elements and sensor processors (e.g., including
one or more circuits for activating a sensor element or for
receiving, processing, storing, displaying or transmitting data
originating from the sensor element) in a capital efficient manner.
Preferably, in this second general embodiment, the apparatus
comprises one or more sensor elements. The sensor element(s) can
have a sensing surface positioned for contact with the fluid.
Preferably, in this second general embodiment, the sensing surface
can be positioned in one or more cavities of a housing. The housing
can be adapted for fluidic interface with a fluid line assembly of
an intravenous fluid delivery system. For example, the housing can
be adapted for in-line fluid communication with the fluid line
assembly. Alternatively, the housing can be defined or included in
an intravenous infusion device (e.g., a catheter). In any case, the
apparatus in this second embodiment, can further comprise one or
more contacts in communication with (e.g, in electrical
communication with) the sensing surface of the sensor element(s).
Such contacts are preferably accessible, to enable a communication
interface with a sensor processor. The sensor processor can be in a
processor assembly which contains the one or more circuits (as
described herein above). The processor assembly can further
comprise one or more contacts in communication with the one or more
circuits. Such contacts are preferably accessible, for intermittent
communication interface with the contacts of the sensing surfaces.
The intermittent interface of this general second embodiment of the
first aspect of the invention allows for deployment of a relatively
inexpensive housing assembly comprising the one or more sensor
element(s), which housing assembly or sensor elements or sensing
surfaces thereof can be sterile or sterilizable for use, and/or
which can be disposable after use. Such housing assembly or sensor
elements or sensing surfaces can be deployed in practice with a
reusable sensor processor (e.g., as a processor assembly), thereby
providing for capital efficiency. For example, a sensor processor
can be interfaced with a first housing assembly for use by a first
subject, and following thereafter, the same sensor processor can be
interfaced with a second housing assembly for use by a second
subject. Further related methods and aspects are described
below.
[0020] In a third general embodiment of the first aspect of the
invention, the invention is directed to an apparatus effective for
ensuring and enhancing the reliability and/or accuracy of a
patient-specific treatment. Preferably, in this third general
embodiment the apparatus comprises one or more sensor elements. The
sensor element(s) can have a sensing surface positioned for contact
with the fluid. Preferably, the sensing surface can be positioned
in one or more cavities of a housing, as described above in
connection with the second general embodiment of the first aspect
of the invention. The apparatus can comprise a sensor processor.
The sensor processor can include one or more circuits for
activating a sensor element or for receiving, processing, storing,
displaying or transmitting data originating from the sensor
element. Preferably, the apparatus can comprise one or more of a
signal processing circuit and/or a data retrieval circuit.
Preferably, the apparatus can further comprise an identifier
circuit for correlating sensor data to a specific patient. The
identifier circuit is preferably in communication with (e.g.,
electrical communication with) one or more of a signal processing
circuit and/or a data retrieval circuit. The identifier circuit can
be used in operation to effectively monitor whether a specific
patient is receiving an intravenous fluid consistent with a
prescribed or proscribed treatment plan.
[0021] In a fourth general embodiment of the first aspect of the
invention, the invention is directed to an apparatus effective for
deploying a fluid-component sensor into in intravenous delivery
system. Preferably, in this fourth general embodiment of the first
aspect of the invention, the apparatus comprises an infusion device
for infusion of fluid into the vasculature system of a subject, and
one or more sensor elements integral with the infusion device. The
sensor element(s) can have a sensing surface positioned for contact
with the fluid. Preferably, the sensing surface can be positioned
in one or more cavities (e.g., of a housing) defined in the
infusion device.
[0022] The first, second, third and fourth general embodiments of
the first aspect of the invention can be effected in combination
with each other. The first, second, third and fourth general
embodiments of the first aspect of the invention can be effected
and/or used as well with each general embodiment of the second and
third aspects of the invention. Various specific subembodiments of
each general embodiments of the first aspect of the invention are
also applicable with specific subembodiments of general embodiments
of the second and third aspects of the invention.
[0023] In a second aspect, the invention is directed to systems for
intravenous delivery of fluids into a subject in need thereof
(e.g., a patient). In general, in this second aspect of the
invention the system comprises a fluid line assembly and one or
more sensor elements. The fluid line assembly can generally include
one or more conduits and for other components. The fluid line
assembly can have a first end adapted for fluid communication with
a fluid source and a second distal end adapted for fluid
communication with an intravenous infusion device for infusion of
fluid into the vascular system of the subject (e.g., a patient).
The sensor element(s) can have a sensing surface positioned for
contact with the fluid. Preferably, in this first general
embodiment of the second aspect of the invention, the sensing
surface can be positioned in one or more cavities of a housing. The
housing can be adapted for fluidic interface with a fluid line
assembly of an intravenous fluid delivery system. For example, the
housing can be adapted for in-line fluid communication with the
fluid line assembly. Alternatively, the housing can be defined or
included in an intravenous infusion device (e.g., a catheter).
[0024] In a first general embodiment of the second aspect of the
invention, the invention is directed to a system for intravenous
fluid delivery to a patient comprising a fluid line assembly and an
apparatus of the first aspect of the invention.
[0025] In a second general embodiment of the second aspect of the
invention, the invention is directed to a system for intravenous
fluid delivery to a patient comprising a fluid line assembly having
a first end adapted for fluid communication with a fluid source and
a second distal end adapted for fluid communication with an
intravenous infusion device for infusion of fluid into the vascular
system of the subject (e.g., a patient). The system further
comprises a sensor element having a sensing surface proximate to
the second distal end of the fluid line assembly. The sensing
surface can be positioned in one or more cavities of a housing. The
housing can be adapted for fluidic interface with a fluid line
assembly proximate to its distal end. For example, the housing can
be adapted for in-line fluid communication with the fluid line
assembly proximate to its distal end. Alternatively, the housing
can be defined or included in an intravenous infusion device (e.g.,
a cannula or a catheter). The system can further comprise one or
more injection ports and one or more additional sensor elements for
one or more additional sensors, such additional sensor elements
being positioned upstream of the injection port--facilitating for
example a differential measurement approach.
[0026] In a third general embodiment of the second aspect of the
invention, the invention is directed to a system for intravenous
fluid delivery to a subject which includes a remote processor,
effective for example for monitoring sensor data from one or from
multiple local sensors (e.g., for remote monitoring of a
corresponding multiple subjects). The remote processor can
therefore comprise a data acquisition circuit for acquiring sensor
data originating from one or more local sensors (e.g, via a
corresponding one or more local processors), and a monitoring
circuit for monitoring the sensor data. The system can include a
local processor comprising one or more circuits for activating a
sensor element or for receiving, processing, storing, displaying or
transmitting data originating from the sensor element. Preferably,
the apparatus can comprise one or more of a signal processing
circuit and/or a data retrieval circuit. Preferably, the system can
further comprise an identifier circuit for correlating sensor data
to a specific patient. The local processor can be proximate to and
in communication with one or more sensing surfaces of a sensor
element. The sensor element can have a sensing surface positioned
to contact the fluid during administration to the subject, as
described.
[0027] In a further, fourth general embodiment of the second aspect
of the invention, the invention is directed to a system for
intravenous fluid delivery to a subject comprising a fluid line
assembly and a sensor for identifying one or more active
pharmaceutical agents within the fluid. The sensor can comprise a
sensor element having a sensing surface positioned for contact with
the fluid, and one or more circuits in communication with the
sensor element for activating the sensor element or for receiving,
processing, storing, displaying or transmitting data originating
from the sensor element. The sensor is configured to
distinguishably detect one or more active pharmaceutical agents.
Preferably, the sensor is configured to identify one or more active
pharmaceutical agents selected from the group consisting of an
anticoagulant (e.g., heparin), a metabolically-active hormone (e.g,
insulin), an anesthetic (e.g., propofol), and an analgesic (e.g.,
morphine).
[0028] In another, fifth general embodiment of the second aspect of
the invention, the invention is directed to a system for
intravenous fluid delivery to a subject comprising a fluid line
assembly and a sensor for identifying one or more components of the
fluid. The sensor can comprise a sensor element having a sensing
surface positioned for contact with the fluid, and one or more
circuits in communication with the sensor element for activating
the sensor element or for receiving, processing, storing,
displaying or transmitting data originating from the sensor
element. The sensor is configured to distinguishably detect one or
more components of the fluid. Preferably, the sensor is configured
to identify one or more components of the fluid selected from the
group consisting of a metal ion, halide ion, organic ion or salts,
and a sugar, preferably for example sodium ion, potassium ion,
chloride ion, calcium ion, magnesium ion, lactate ion, and
dextrose. For example, such ions can be components in fluid
compositions comprising potassium chloride, sodium chloride,
Ringer's lactate, and dextrose. Preferably, the method comprises
sensing the fluid to identify potassium chloride, potassium ion or
chloride ion.
[0029] In a sixth general embodiment of the second aspect of the
invention, the invention is directed to a system for intravenous
fluid delivery to a subject comprising a fluid line assembly and a
sensor other than a flow sensor, the sensor comprising a sensor
element having a sensing surface positioned for contact with the
fluid. The sensor can preferably further comprise one or more
circuits in communication with the sensor element for activating
the sensor element or for receiving, processing, storing,
displaying or transmitting data originating from the sensor
element.
[0030] The first, second, third, fourth, fifth and sixth general
embodiments of the second aspect of the invention can be effected
in combination with each other. The first, second, third, fourth,
fifth and sixth general embodiments of the second aspect of the
invention can be effected and/or used as well with each general
embodiment of the first and third aspects of the invention. Various
specific subembodiments of each general embodiments of the second
aspect of the invention are also applicable with specific
subembodiments of general embodiments of the first and third
aspects of the invention.
[0031] In a third aspect, the invention is directed to methods for
intravenous delivery of fluid to a subject in need thereof (e.g., a
patient). In general, such methods comprise administering an
intravenous fluid to a subject in need thereof and sensing the
fluid, preferably to identify one or more components thereof.
[0032] In a first general embodiment of the third aspect of the
invention, the invention is directed to a method for intravenous
delivery of fluid to a subject in need thereof. The method
comprises administering the fluid to the subject, and sensing the
fluid with an apparatus of the first aspect of the invention or
with a system of the second aspect of the invention. Preferably,
the method further comprises identifying one or more components of
the fluid during administration of fluid to the subject.
[0033] In a second general embodiment of the third aspect of the
invention, the invention is directed to a method for intravenous
delivery of fluid to a subject in need thereof. The method
comprises administering the fluid to the subject, sensing the fluid
to generate a multi-parameteric profile characteristic of a
component of the fluid, and identifying one or more components of
the fluid during administration of fluid to the subject based on
the multi-parametric profile. In preferred subembodiments, sensing
the fluid comprises exposing a sensing surface of a first sensor
element to the fluid, exposing a sensing surface of a second sensor
element to the fluid, and independently processing data originating
from each of the first sensor element and the second sensor element
to generate the multi-parametric profile.
[0034] In a third general embodiment of the third aspect of the
invention, the invention is directed to a method for intravenous
delivery of fluid to a subject in need thereof. The method
comprises administering a first fluid to a first subject, exposing
a sensing surface of a first sensor element to the first fluid,
interfacing (e.g., communicatively engaging) a processor with the
first sensor element and identifying one or more components of the
first fluid during administration thereof to the first subject. The
processor can comprise one or more circuits for activating a sensor
element or for receiving, processing, storing, displaying or
transmitting data originating from the a sensor element. The method
further comprises dis-interfacing (e.g., communicatingly
disengaging) the processor from the first sensor element. The
method further comprises administering a second fluid to a second
subject, exposing a sensing surface of a second sensor element to
the second fluid, and interfacing the (same) processor with the
second sensor element and identifying one or more components of the
second fluid during administration thereof to the second subject.
This method preferably, in a subembodiment, can further comprise
disposing or sterilizing the sensing surface of each of the first
sensor element and the second sensor element after administration
of fluid to the respective subject.
[0035] In a fourth general embodiment of the third aspect of the
invention, the invention is directed to a method for intravenous
delivery of fluid to a subject in need thereof. The method
comprises administering the fluid to the subject, sensing the fluid
to generate sensor data for identifying one or more components of
the fluid during administration of fluid to the subject, and
correlating the sensor data to the specific subject. Preferably,
this method can further comprise deriving one or more parameters
from the sensor data, and comparing the one or more sensor-derived
parameters with one or more prescribed or proscribed
patient-relevant parameters.
[0036] In a fifth general embodiment of the third aspect of the
invention, the invention is directed to a method for intravenous
delivery of fluid to a subject in need thereof. The method
comprises administering the fluid to the subject through an
intravenous infusion device, and sensing the fluid with a sensing
surface of a sensor element, where the sensing surface is
positioned proximate to the intravenous infusion device to identify
one or more components of the fluid during administration of fluid
to the subject. Preferably in this method, fluid is exposed to a
sensing surface of a sensor element, with the sensing surface being
positioned within a cavity of a housing adapted for in-line fluid
communication of a fluid line assembly. Preferably in this method,
such an in-line housing is positioned directionally adjacent to the
subject relative to the position of any fluid source supply line or
any injection port of the fluid line assembly. Alternatively for
this method, fluid is exposed to a sensing surface of a sensor
element, and the sensing surface being positioned within a cavity
of a housing defined in the intravenous infusion device.
[0037] In a sixth general embodiment of the third aspect of the
invention, the invention is directed to a method for intravenous
delivery of fluid to a subject in need thereof. The method
comprises administering the fluid to the subject, sensing the fluid
with a sensor element having a sensing surface exposed to the fluid
during administration of fluid to the subject, generating sensor
data in a processor local to and in communication with the sensor
element, the local processor optionally comprising one or more
circuits for activating a sensor element, the local processor
comprising one or more circuits for receiving, processing, storing,
displaying or transmitting data originating from the sensor
element. The method further comprises acquiring the sensor data at
a processor remote from the sensor element. The remote processor
can comprise one or more circuits for receiving, processing,
storing, displaying or transmitting the acquired sensor data. The
method further comprises monitoring the acquired sensor data or
data derived therefrom.
[0038] In a seventh general embodiment of the third aspect of the
invention, the invention is directed to a method for intravenous
delivery of fluid to two or more subjects in need thereof. The
method comprises administering a first fluid to a first subject,
sensing the first fluid with a first sensor element having a
sensing surface exposed to the first fluid during administration of
fluid to the first subject, and generating sensor data in a first
processor local to and in communication with the first sensor
element. The method further comprises administering a second fluid
to a second subject, sensing the second fluid with a second sensor
element having a sensing surface exposed to the second fluid during
administration of fluid to the second subject, and generating
sensor data in a second processor local to and in communication
with the second sensor element. The method can further include
acquiring the sensor data from each of the first local processor
and the second local processor at a processor remote from each of
the first sensor element and the second sensor element, and
monitoring the acquired sensor data from each of the first local
processor and the second local processor or monitoring data derived
therefrom.
[0039] In an eighth general embodiment of the third aspect of the
invention, the invention is directed to a method for intravenous
delivery of fluid to two or more subjects in need thereof. The
method comprises administering the fluid to the subject, and
sensing the fluid to identify one or more active pharmaceutical
agents within fluid during administration of fluid to the subject.
Preferably, the method of this eighth general embodiment comprises
sensing the fluid to identify one or more active pharmaceutical
agents selected from the group consisting of: an anticoagulant
(e.g, heparin), a metabolically-active hormone (e.g., insulin), an
anesthetic (e.g, propofol), and an analgesic (e.g, morphine).
[0040] In a ninth general embodiment of the third aspect of the
invention, the invention is directed to a method for intravenous
delivery of fluid to two or more subjects in need thereof. The
method comprises administering the fluid to the subject, sensing
the fluid to identify one or more components within fluid during
administration of fluid to the subject, the one or more components
being selected from the group consisting of a metal ion, halide
ion, organic ion or salts, and a sugar, preferably for example
sodium ion, potassium ion, chloride ion, calcium ion, magnesium
ion, lactate ion, and dextrose. For example, such ions can be
components in fluid compositions comprising potassium chloride,
sodium chloride, Ringer's lactate, and dextrose. Preferably, the
method comprises sensing the fluid to identify potassium chloride,
potassium ion or chloride ion.
[0041] The first, second, third, fourth, fifth, sixth, seventh,
eighth and ninth general embodiments of the third aspect of the
invention can be effected in combination with each other. The
first, second, third, fourth, fifth, sixth, seventh, eighth and
ninth general embodiments of the third aspect of the invention can
be effected and/or used as well with each general embodiment of the
first and second aspects of the invention. Various specific
subembodiments of each general embodiments of the third aspect of
the invention are also applicable with specific subembodiments of
general embodiments of the first and second aspects of the
invention.
[0042] Various embodiments of the invention as described above and
hereinafter include listings of groups of alternatives (e.g,
Markush groups); in each case, any such listing is intended to
disclose each such member of the group collectively as well as
individually.
[0043] Various features of the invention, including features
defining each of the various aspects of the invention, including
general and preferred embodiments thereof, can be used in various
combinations and permutations with other features of the invention.
Features and advantages are described herein, and will be apparent
from the Drawings and the following detailed description.
BRIEF DESCRIPTION OF THE DRAWINGS
[0044] FIG. 1(A-C) illustrate schematic representations of
intravenous fluid delivery systems, including a contextual
schematic illustration showing general features (FIG. 1A), and more
detailed schematic illustrations showing further features thereof
(FIG. 1B, FIG. 1C).
[0045] FIG. 2 illustrates a schematic representation of an
embodiment of an apparatus comprising a sensor element having a
sensing surface integrated into an in-line housing adapted for
fluidic interface with a fluid line assembly.
[0046] FIG. 3(A-C) illustrate schematic representations of an
embodiment of an apparatus comprising a sensor element having a
sensing surface integrated into an intravenous infusion device
(e.g., catheter) adapted for fluid communication with fluid line
assembly, including a perspective view (FIG. 3A), side cut-away
elevation (FIG. 3B), and detail of the sensor element containing
portion thereof (FIG. 3C).
[0047] FIG. 4 illustrates a schematic representation of a
multi-parametric approach for identifying one or more components of
the intravenous fluid.
[0048] FIG. 5(A-E) illustrate schematic representations of various
circuits associated with sensors of various aspects and embodiments
of the inventions, including independently: a block diagram of a
specific preferred circuit configuration (FIG. 5A); a high-level
schematic diagram showing a sensor element configured in an
assembly such as a housing assembly, and various circuits being
configured in an assembly such as housing assembly, and/or in a
local processor and/or in a remote processor (FIG. 5B); and
additional high-level schematic diagrams showing alternative
configurations for a system comprising (i) a (one or more) sensor
element, (ii) a signal-conditioning processor, including one or
more circuits adapted for conditioning (e.g, amplifying) a signal,
and (iii) a signal-identification processor, including one or more
circuits adapted for identifying or determining a signal
representative of the identity of one or more components of an
intravenous fluid (e.g. as corresponding to a component within a
composition or concentration of a component within a composition)
(FIG. 5C through 5E).
[0049] FIG. 6(A-G) illustrate schematic representations of various
sensors, including an optic fiber refractive index sensor (FIG.
6A), an electrochemical potential sensor (FIG. 6B), and various
schematic views of an integrated assembly comprising impedance and
refractive index sensor elements (FIG. 6C through FIG. 6G),
including a perspective view of the integrated sensor element
assembly (FIG. 6C), a top-plan view of a first surface of a first
substrate thereof (FIG. 6D), a detail of the sensing surfaces of
the impedance sensor elements as shown therein (FIG. 6E), a
perspective assembly view of the first substrate and a second
substrate, shown with a functional communication port, such as a
USB port (FIG. 6F), and a perspective view of the (assembled)
integrated assembly of impedance/refractive index sensor elements
(FIG. 6G).
[0050] FIG. 7(A-D) illustrate various data derived from Example 2,
including plots of measurements of admittance, real portion (FIG.
7A), admittance, imaginary portion (FIG. 7B), optical refractive
index (FIG. 7C), and a multi-parametric representation of such
measurements (FIG. 7D).
[0051] FIG. 8(A-D) illustrate various data derived from Example 3,
including plots of measurements of admittance, real portion (FIG.
8A), admittance, imaginary portion (FIG. 8B), optical refractive
index (FIG. 8C), and a multi-parametric representation of such
measurements (FIG. 8D).
[0052] FIG. 9(A-B) illustrate various data derived from Example 4,
including plots of measurements of out-of-phase current (y-axis)
and in-phase current (x-axis) for injections of potassium chloride
(KCl) and magnesium sulfate (MgSO.sub.4) (FIG. 9A), as well as for
subsequent injections with water.
[0053] Various aspects of the figures are described in further
detail below, in connection with the Detailed Description of the
Invention.
DETAILED DESCRIPTION
[0054] The present inventions provide apparatus, systems and
methods related to intravenous fluid administration. The apparatus,
systems and methods of the invention are more specifically related
to monitoring of intravenous fluids during administration to a
subject.
[0055] Generally, as summarized above and described in further
detail below, the apparatus, systems and methods of the invention
are directed to or effective for identifying one or more components
of an intravenous fluid during administration of the fluid to a
subject. Preferably, the apparatus, systems and methods of the
invention are directed to or effective for identifying one or more
active pharmaceutical agents within an intravenous fluid during
administration of the fluid to a subject. Other components can also
be detected, especially components relevant to hydration and/or ion
metastasis (e.g., electrolyte balance) and/or vasculature pressure
of patients. The one or more components of an intravenous fluid can
preferably be identified during administration of the fluid to a
subject using a multi-parametric approach. Many specific sensors
known in the art can be used in connection with the various aspects
and embodiments of the invention. Preferred sensors include one or
more sensors selected from an impedance sensor (e.g, an AC
impedance spectroscopy sensor), an electrochemical sensor (e.g., an
electrochemical potential sensor), a thermal sensor (e.g., a
thermal anemometer sensor), an optical sensor (e.g., a
refractometry sensor, a transmission sensor, an absorbance sensor,
a spectrometer (including a colorimeter), a turbidity sensor), a
rheological sensor (e.g., a viscometer), an electrical property
sensor (e.g., a capacitor sensor, a pH sensor, a conductivity
sensor, and an inductive sensor), and a fluid-displacing or
fluid-shearing (e.g, resonator) sensor. Preferably, a system
comprises two or more sensors, for example an integrated assembly
comprising two or more sensor elements, each comprising one or more
sensing surfaces (e.g, an impedance sensor and an optical (e.g,
refractive index) sensor). Preferably, a sensor having a sensor
element (e.g., with a sensing surface adapted for interaction with
and being responsive to the intravenous fluid) is positioned such
that the sensor element (e.g., the sensing surface) within an
intravenous fluid system such that it interacts with the fluid
(e.g, such sensing surface contacts the fluid) in relative
proximity to the infusion location--the location at which the fluid
enters a subject's vasculature system, e.g., proximal to the distal
end of the fluid line assembly or proximal to the intravenous
infusion device. Preferably, the apparatus, systems and method of
the invention provide for the subject being positively and
specifically identified in connection with monitoring and
administration of the intravenous fluid; hence, for example, the
sensor (or apparatus or system comprising a sensor) can include an
identifier circuit for correlating sensor data to a specific
subject. Preferably, the systems are effected with a remote and/or
centralized monitoring approach. For example, different sensor data
from one subject or from several different subjects (in each case,
such sensor data being locally generated and specifically
associated with an intravenous fluid being administered to a
particular subject) can be acquired and/or monitored at a location
which is remote (relative to the patient)--such as a nursing
station; preferably such sensor data can be centrally monitored at
such remote location. For example and without limitation,
monitoring can be visual by human interaction with a display and/or
can be further enhanced and effected by various automated
approaches, including automated approaches involving notice to
caregivers (alarms, emails, text message) and/or specific
corrective or subsequently prescribed actions within the system. In
preferred embodiments of various aspects of the invention, the
sensor can comprise a processor which is physically separable from,
and conversely, intermittently interfaceable with a sensor element
Such temporally-limited engagement (interfacement) of processor and
sensor element allows for an operational period (while
engaged/interfaced) and a non-operational period (with physical
separation of sensor element from the processor). The
non-operational period can allow for sterilizing the sensor element
(or a sensing surface thereof) or for disposal and replacement of a
(pre-)sterilized sensor element (or a sensing surface thereof). The
processor can be re-used, for example, in connection with a second
subject, either in the same location (a later subject) or in a
different location (e.g., multiplexing the same processor over
various subjects). In preferred embodiments of various aspects of
the invention, the sensor can comprise: an assembly comprising one
or more sensor elements; a signal-conditioning processor, including
one or more circuits adapted for conditioning (e.g, amplifying) a
signal; and a signal-identification processor, including one or
more circuits adapted for identifying or determining a signal
representative of the identity of one or more components of an
intravenous fluid. The various aforementioned attributes and
features of the inventions can be used in each of the various
possible combinations and permutations with each other, as
applicable.
[0056] As described herein and in further detail below, the various
inventions offer intravenous fluid monitoring approaches which are
significantly advantaged over known systems, including for example
by providing near real-time monitoring of the identity of one or
more components of an intravenous fluid (e.g., the presence or
absence of a component, the composition of a component, the
concentration of a component, the time of infusion (absolute time
or relative time versus other components), the onset of component
delivery; the completion of component infusion, the cumulative
dosing level (e.g., current or projected) of a component being
delivered, etc.). Such near real-time monitoring of intravenous
fluids reduces the potential for errors associated with intravenous
administration, and especially intravenous drug administration.
Hence, the apparatus, systems and methods of the invention provide
substantial advances in patient safety. Such advances in safety can
translate to a more meaningful patient treatment experience, and to
enhanced operational efficiencies and reduced expenses for
hospitals and other entities which administer fluids intravenously.
Such inventions can applied, and such advantages can be realized in
a number of various settings and applications in which intravenous
fluids are administered, including for example, without limitation,
at hospitals, clinics, surgical centers, homes (e.g., home
hospice), nursing homes, assisted living environments, etc.
[0057] Intravenous Fluid Delivery Systems
[0058] Generally, an intravenous fluid delivery system of the
invention can include various systems known in the art or later
developed which provide for delivery of fluids to the vasculature
system of a subject in need thereof. Generally, such systems can be
intermittent or continuous (e.g., including intravenous drip
systems). With reference to FIGS. 1A through 1C, in operation
intravenous fluid delivery systems generally comprise an
intravenous fluid source 100 in fluid communication with an
intravenous infusion device 300 through a fluid line assembly 200.
The intravenous infusion device 300 is adapted for infusion of
fluid into the vasculature system (e.g., a vein) of a subject 10.
With further reference to FIG. 2 and FIGS. 3A through 3C, the
intravenous fluid delivery systems of the invention can comprise a
sensor 500 comprising one or more sensor elements 502 having a
sensing surface 504. The sensing surface 504 can be in
communication (e.g., electrical communication via electrical
connector 506) to one or more contacts 508).
[0059] Various intravenous fluid delivery system configurations can
be employed, and various such intravenous infusion devices can be
employed. For example, the intravenous fluid delivery system can be
configured for peripheral intravenous infusion, for central
intravenous infusion, or for peripherally-inserted central
intravenous infusion. The system can be adapted for various
infusion profiles and approaches; for example, infusion can be
rapid, can be drip, can be continuous or can be intermittent.
[0060] Various suitable intravenous infusion device can be used in
connection with the invention. Preferably, as shown in the FIGS. 1A
through 1C, such intravenous infusion devices 300 can be integrated
with or in fluid communication with a fluid line assembly 200
and/or a fluid source 100. Generally, and with reference to FIGS.
3A through 3C, such an intravenous infusion device 300 (e.g, a
catheter) can comprise a first end 310 adapted for fluid
communication with a fluid line assembly, a second distal end 320
adapted for insertion through the skin into the vasculature system
of the subject, preferably through a peripheral vein, and a housing
330 (e.g, a catheter hub), providing excorporal structural support
and having a cavity 340 providing fluid communication between the
first end 310 and the second distal end 320 of the infusion device.
The intravenous infusion device 300 can also include a support
element 390 (e.g, such as adhesive wings) for supporting the device
300 during administration of fluid to a subject. Other intravenous
infusion devices can also be used in connection with aspects and
embodiments of the inventions. Such devices can include for example
an integrated fluid source--for example, a needle-type infusion
device (e.g, comprising a syringe a needle in fluid communication
with the syringe). Such devices can also include ported cannulae
having an injection port on a first end and a second distal end
adapted for insertion through the skin into the vasculature system
of the subject. The intravenous infusion device can also include an
implantable infusion device such as an implantable port. The port
can be, for example, a central venous line comprising a cavity
covered with a pliable sealant as a cavity cover (e.g, silicone
rubber) and adapted for being implanted under the skin. A fluid can
be administered through such implantable port intermittently by
placing a small needle or catheter through the skin, piercing the
silicone, and administering the fluid into the cavity. The cavity
cover can reseal after withdrawal of the needle or catheter.
[0061] Other system components can include, for example in a
typical intravenous fluid delivery system, one or more sterile
containers (glass bottle, plastic bottle or plastic bag) adapted
for containing (or pre-filled to contain) fluids, typically
configured with an attached drip chamber. The system can comprise a
fluid line assembly comprising one or more conduit sections (e.g,
each conduit for example comprising a long sterile tube),
optionally configured with a clamp to regulate or stop the flow,
various connectors, one or more infusion pumps, adapted for
providing control over the flow rate and total amount of fluid
delivered.
[0062] Pharmaceutical Agents, Other Components and Preferred
Sensors
[0063] Generally, the apparatus, systems and methods of the
invention are directed to or effective for identifying one or more
components of an intravenous fluid during administration of the
fluid to a subject. The intravenous fluid is not narrowly critical
and can be of various types, including generally for example
crystalloid solutions and colloid solutions. Crystalloid solutions
can comprise aqueous solutions of mineral salts or other
water-soluble molecules, including active pharmaceutical agents.
Colloids can comprise larger semi-soluble or insoluble molecules,
including active pharmaceutical agents. Generally, the intravenous
fluids are sterile fluids.
[0064] Preferably, the apparatus, systems and methods of the
invention are directed to or effective for identifying one or more
active pharmaceutical agents within an intravenous fluid during
administration of the fluid to a subject. Such active
pharmaceutical agents can include, for example, an anticoagulant
(e.g., heparin), a metabolically-active hormone (e.g, insulin), an
anesthetic (e.g., propofol), and/or an analgesic (e.g., morphine),
among others. Various one or more sensors are configured for
sensing a property of a fluid which can be correlated to identify
an active pharmaceutical agent component of the fluid. For example,
the sensor can comprise one or more sensor elements having a
sensing surface positioned for contact with the fluid, and one or
more circuits in communication with the sensor element for
activating the sensor element or for receiving, processing,
storing, displaying or transmitting data originating from the
sensor element. The sensor can be configured to distinguishably
detect one or more active pharmaceutical agents. Preferably, the
sensor is configured to identify one or more active pharmaceutical
agents selected from the group consisting of an anticoagulant
(e.g., heparin), a metabolically-active hormone (e.g, insulin), an
anesthetic (e.g., propofol), and an analgesic (e.g., morphine).
[0065] Additionally or alternatively, the apparatus, systems and
methods of the invention are directed to or effective for
identifying one or more other components of an intravenous fluid,
preferably components used for hydration and ion metastasis of
subjects. Such components can preferably include, for example one
or more components selected from potassium chloride, sodium
chloride, Ringer's lactate, and dextrose, in each case in molecular
or ionic (e.g, dissociated) form (e.g, sodium ion, potassium ion,
chloride ion, calcium ion, lactate ion, and dextrose). The sensor
can comprise a sensor element having a sensing surface positioned
for contact with the fluid, and one or more circuits in
communication with the sensor element for activating the sensor
element or for receiving, processing, storing, displaying or
transmitting data originating from the sensor element. The sensor
can be configured to distinguishably detect one or more components
of the fluid. Preferably, the sensor is configured to identify one
or more components of the fluid selected from the group consisting
of a metal ion, halide ion, organic ion or salts, and a sugar,
preferably for example sodium ion, potassium ion, chloride ion,
calcium ion, magnesium ion, lactate ion, and dextrose. For example,
such ions can be components in fluid compositions comprising
potassium chloride, sodium chloride, Ringer's lactate, and
dextrose. Preferably, the method comprises sensing the fluid to
identify potassium chloride, potassium ion or chloride ion.
[0066] Typical intravenous fluids can comprise normal saline,
preferably for example a solution of sodium chloride at 0.9%
concentration, which is close to the concentration in the blood
(isotonic). The intravenous fluid can comprise Ringer's lactate or
Ringer's acetate, another isotonic solution. In some instances, the
intravenous fluid can comprise a sugar such as dextrose, for
example a solution of 5% dextrose in water, sometimes referred to
as D5W. The selection of a particular carrier fluid may also depend
on the chemical properties of the active pharmaceutical agents
being administered.
[0067] Table I shows compositions of common intravenous fluids used
in connection with intravenous fluid delivery systems.
TABLE-US-00001 TABLE 1 Composition of Intravenous Fluid Solutions
[Na.sup.+] [Cl.sup.-] [Glucose] [Glucose] Solution Other Name
(mmol/L) (mmol/L) (mmol/L) (mg/dl) D5W 5% Dextrose 0 0 278 5000
2/3D & 3.3% Dex- 51 51 185 3333 1/3S trose/0.3% saline Half-
0.45% NaCl 77 77 0 0 Normal Saline Normal 0.9% NaCl 154 154 0 0
saline Ringer's Lactated 130 109 0 0 lactate Ringer Ringer's
lactate also typically can have, for example and without limitation
28 mmol/L lactate. 4 mmol/L K+ and 3 mmol/L Ca2+.
[0068] Generally, and preferably, the apparatus, systems and
methods of the invention are directed to or effective for
identifying one or more components of an intravenous fluid during
administration of the fluid to a subject using one or more sensors.
The one or more sensors are preferably selected to include at least
one sensor other than a flow sensor, and/or in some embodiments
also preferably other than a pressure sensor, and/or in some
embodiments also preferably other than an ultrasonic sensor.
Generally for example, preferred sensors effective with the
apparatus, systems and methods of the invention can include,
without limitation, one or more sensors selected from an impedance
sensor (e.g, an AC impedance spectroscopy sensor), an
electrochemical sensor (e.g., an electrochemical potential sensor),
a thermal sensor (e.g., a thermal anemometer sensor), an optical
sensor (e.g., a refractometry sensor, a transmission sensor, an
absorbance sensor, a spectrometer (including a colorimeter)r, a
turbidity sensor), a rheological sensor (e.g., a viscometer), an
electrical property sensor (e.g., a capacitor sensor, a pH sensor,
a conductivity sensor, and an inductive sensor), and a
fluid-displacing (e.g, resonator) sensor. The various specific
sensors and sensing approaches as described herein are preferred,
an can be generally used with any aspects, embodiments and
approaches described herein; however, many aspects, embodiments and
approaches of the invention do not require such certain specific
sensors or sensing techniques and can be effected independently
thereof.
[0069] Generally, the sensor can be adapted for identifying an
anticoagulant, preferably heparin. Preferably the sensor is adapted
for determining one or more properties of the fluid selected from
electrochemical potential, impedance, refractive index and
ultraviolet absorption, and for identifying an anticoagulant,
preferably heparin, based on the one or more determined
properties.
[0070] Generally, the sensor can be adapted for identifying a
metabolically-active hormone, preferably insulin. Preferably, the
sensor is adapted for determining one or more properties of the
fluid selected from electrochemical potential, impedance,
refractive index and visible absorption (color), and for
identifying a metabolically-active hormone, preferably insulin,
based on the one or more determined properties.
[0071] Generally, the sensor can be adapted for identifying an
anesthetic, preferably propofol. Preferably, the sensor is adapted
for determining one or more properties of the fluid selected from
electrochemical potential, impedance, refractive index and visible
absorption (color), and for identifying an anesthetic, preferably
propofol, based on the one or more determined properties.
[0072] Generally, the sensor can be adapted for identifying an
analgesic, preferably morphine. The invention of claim 80 wherein
the sensor is adapted for determining one or more properties of the
fluid selected from electrochemical potential, impedance,
refractive index and ultraviolet absorption, and for identifying an
analgesic, preferably morphine, based on the one or more determined
properties.
[0073] Generally, the sensor can be adapted for identifying one or
more components selected from the group consisting of a metal ion,
a halide ion, an organic ion or salt, and a sugar.
[0074] Generally, the sensor can be adapted for identifying
potassium chloride, potassium ion or chloride ion. Preferably, the
sensor is adapted for determining one or more properties of the
fluid selected from electrochemical potential, impedance,
refractive index and ultraviolet absorption, and for identifying
potassium chloride, potassium ion or chloride ion based on the one
or more determined properties.
[0075] Generally, in each of the above preferred embodiments, the
sensor can be adapted for determining two or more properties of the
fluid, and for identifying the one or more active pharmaceutical
agents based on the two or more determined properties.
[0076] Preferred sensors and fluid properties for sensing various
active pharmaceutical agents (e.g. drug formulations) and other
components are shown in Table 2.
TABLE-US-00002 TABLE 2 Preferred Fluid Properties and Sensors for
Various Fluid Components Example Fluid Property Sensor Approach
Reference Complex conductivity AC impedance spectroscopy (1) or
admittance Ionic properties Electrochemical potential (2) Thermal
properties Pulsed thermal anemometry, (3) Index of refraction
Refractometer, fiber optic (4) refractometer Optical absorption
Optical absorption spectrometry (5) Color Spectrometer, colorimeter
(6) Viscosity Viscometer, resonator (7) Density Viscometer,
resonator (8) Dielectric constant Capacitor, resonator (9)
Turbidity Turbidity sensor (10) Permeability Chemical sensors with
selective (11) membranes Ph Ph meter, MEMS Ph sensor, (12) chemical
color change sensor, litmus (e.g., paper) Conductivity DC and or AC
conductance (13) Air bubbles Optical (14) Surface plasmon Surface
Plasmon sensor (15) effects Thermal lensing Optical detection of
refractive (16) index change Sono-luminescence Colorimetric and
spectral detection (17) spectroscopy of species Flow rate Thermal
anemometer, Doppler flow (18) meter
[0077] Generally, such sensor approaches and fluid-property
measurements as shown in Table 2 can be effective for
identification of one or more active pharmaceutical agents, or an
intravenous solution component (e.g., saline, potassium chloride,
dextrose, etc.), in each case within an intravenous fluid during
administration of the fluid to a subject. Chemical sensors with
selective membranes can differentiate fluid permeability and be
useful for example for identifying specific compounds selectively
(e.g, based on selection of a particular membrane). Optical
detection of air bubbles, can be effective for example for
preventing an air embolism, and additionally or alternatively, for
detecting flow system failures (and thereby helping to maintain
flow). Measurement of flow rate by thermal anemometer and/or by
Doppler flow meter can be effective, for example, for detecting
blockages, controlling flow rate, determining dosing and detecting
flow system failures (and thereby helping to maintain flow).
[0078] Without limitation, and without being bound by theory not
expressly recited in the claims, the following references are
representative examples of the sensor approach and/or the fluid
property measurement as shown in Table 2: [0079] (1) Impedance
based flow sensors Green, N. G., Tao, S., Holmes, D. and Morgan, H.
(2005) Impedance based flow sensors. In: Microtechnologies for the
New Millennium 2005 SPIE, 9-11 May 2005. [0080] (2)
http://www.resonancepub.com/electrochem.htm [0081] (3) A
pulsed-wire technique for velocity and temperature measurements in
natural convection flows; Journal Experiments in Fluids; Publisher:
Springer Berlin/Heidelberg; ISSN 0723-4864 (Print) 1432-1114
(Online) Issue Volume 18, Numbers 1-2/December, 1994 [0082] (4)
Refractive Index Measurement and its Applications; Shyam Singh 2002
Phys. Scr. 65 167-180 doi: 10.1238/Physica.Regular.065a00167 [0083]
(5) http://www.doas-bremen.de/paper/spec_euro.sub.--06_richter.pdf
[0084] (6)
http://www.optek.com/Application_Note/General/English/7/Inline_Process-_C-
olor_Measurement.asp [0085] (7)
http://www.coleparmercom/techinfo/techinfo.asp?htmlfile=why-meas-viscosit-
y.htm&ID=933 [0086] (8) Simultaneous Measurements at U-tube
Density Sensors in Fundamental and Harmonic Oscillation; Krasser,
E.; Senn, H.; EUROCON, 2007. The International Conference on
"Computer as a Tool"; Volume, Issue, 9-12 Sep. 2007 Page(s):551-555
[0087] (9) www.tmworld.com/contents/pdf/tmw03.sub.--05D1_jr.doc
[0088] (10) http://www.omega.fr/techref/ph-6.html [0089] (11) A new
method for the determination of membrane permeability by spatially
resolved concentration measurements; Bernd Schirmer et al 2004
Meas. Sci. Technol. 15 195-202 doi: 10.1088/0957-0233/15/1/027
[0090] (12) http://www.sensorland.com/HowPage037.html [0091] (13)
Sensor for measuring surface fluid conductivity in vivo; Fouke, J.
M.; Wolin, A. D.; Saunders, K. G.; Neuman, M. R.; McFadden, E. R.,
Jr. Biomedical Engineering, IEEE Transactions Volume 35, Issue 10,
October 1988 Page(s): 877-881 [0092] (14)
http://www.us.endress.com/eh/sc/america/us/en/home.nsf/imgref/D7A94F6-80B-
2EA516C12 573A8007833A6/$FILE/T1921C-OUSAF13.pdf [0093] (15)
Surface Plasmon Resonance Based Sensors; Springer Series on
Chemical Sensors and Biosensors, Vol. 4 Homola, Jiri (Ed.) 2006,
XII, 251 p. 134 illus. Hardcover ISBN: 978-3-540-33918-2 [0094]
(16) Flowing thermal lens micro-flow velocimeter; Yoshikuni
Kikutania, b, Kazuma Mawataria, b, Kenji Katayamaa, b, Manabu
Tokeshia, b, c, Takashi Fukuzawac, d, Mitsuo Kitaokab and Takehiko
Kitamor; Sensors and Actuators B; Chemical; Volume 133, Issue 1, 28
Jul. 2008, Pages 91-96 [0095] (17) Malcolm J. Crocker, Handbook of
Acoustics, Ch. 4, 1998 [0096] (18) A thermoelectric sensor for
fluid flow measurement. principles, calibration and solution for
self temperature compensation; H. Stachowiaka, S. Lassuea, A.
Dubernarda and E. Gaviotb; Flow Measurement and Instrumentation;
Volume 9, Issue 3, September 1998, Pages 135-141.
[0097] Generally, and preferably, the apparatus, systems and
methods of the invention are directed to or effective for
identifying one or more components of an intravenous fluid during
administration of the fluid to a subject using a sensor having a
sensor element (e.g., with a sensing surface adapted for
interaction with and being responsive to the intravenous fluid),
where such sensor element (e.g., such sensing surface) is
positioned at a location within an intravenous fluid system such
that it interacts with the fluid (e.g, such sensing surface
contacts the fluid) in relative proximity to the infusion
location--the location at which the fluid enters a subject's
vasculature system.
[0098] In various embodiments of various aspects of the invention,
therefore, the apparatus, systems and methods of the invention
comprise a sensor element (e.g., having a sensor surface)
positioned proximal to (e.g, at or near) the distal end of a fluid
line assembly, and/or proximal to an infusion device. For example,
with reference to FIGS. 1A through 1C and to FIG. 2, such a sensor
500 can comprise a sensor element 502 which can include a sensing
surface 504 in a cavity 540 of an in-line housing 530, where the
in-line housing optionally has inlet 510 and outlet 520, each
configured with fittings 212 (e.g., Luer Locks), and can be
integrated into the fluid line assembly upstream of an infusion
device 300. Alternatively, for example, and with reference to FIG.
3A through 3C, such a sensor element 502 can include a sensing
surface 504 in a cavity of a housing (hub 330) defined in infusion
device 300 (e.g., catheter, needle, etc.). Preferably, with further
reference to FIGS. 3A through 3C, the sensor element can be
integrated into an intravenous infusion device such as a catheter.
In exemplary embodiments, for example, the infusion device can have
a first end adapted for fluid communication with a fluid line
assembly, a second distal end adapted for insertion through the
skin into the vasculature system of the subject, preferably through
a peripheral vein, and a housing (e.g., the hub of a catheter)
providing excorporal structural support and having a cavity
providing fluid communication between the first end and the second
distal end of the intravenous infusion device. For example, such
housing can be integral with the hub of a catheter. One or more
sensor elements can each have a sensing surface positioned within
the cavity for contact with the fluid.
[0099] Optionally, in some embodiments, the apparatus, systems and
methods of the invention can comprise one or more first sensor
elements positioned proximal to the distal end of a fluid line
assembly, and/or proximal to an infusion device, at least one
injection port (including for example fluid line from an
intravenous pump subsystem) upstream of such first sensor elements,
and one or more additional second sensor elements positioned
upstream of such injection port--facilitating for example a
differential measurement approach. Significantly, such second
sensor element(s) can be configured to detect a baseline
intravenous fluid (e.g, saline or Ringer's lactate), thereby
providing a basis to compensate measurements made with the first
sensor element(s) for the baseline signal, as well as for any
background signal noises associated with the baseline fluid. Such a
configuration can improve overall sensor sensitivity, and can
thereby enable measurement and identification of components in more
complex intravenous compositions. The second upstream sensors can
be positioned in the intravenous fluid source container or proximal
thereto, for example in a fluid line proximal to an intravenous
fluid source container.
[0100] Generally, the sensors of the invention can be used in
combination with one or more additional sensors, including without
limitation sensors such as thermal (e.g, temperature) sensors
and/or flow sensors. For examples, a thermal (e.g., temperature)
sensor can include a resistance temperature detector (RTD)
configured as known in the art. For example, flow sensors can
include a set of two or more physically separated sensor elements,
which can determine flow based on detection of a specific component
at each sensor element over a measured period of time. Other known
approaches for flow sensor(s) can also be effected. For example,
flow sensors based on Doppler flow measurement, thermo-annemometer
measurement, electro anemometer measurement and/or acoustic
anemometer measurement can be effected in combination with sensors
of the invention.
[0101] Generally, the one or more sensor elements can be activated
using an activation circuit. The activation signal is not narrowly
critical, and can comprise for example a sinusoidal or
non-sinusoidal (e.g., square wave) activation signal (e.g., a
voltage or current). In each case, the activation signal provided
to the sensor element(s) can have a varying amplitude, a varying
frequency and/or can be a pulsed signal. Non-steady or modulated
wave forms, such as amplitude modulated (AM) or frequency modulated
(FM) or pulse modulated (PM), or a combination of any of the
foregoing can be employed. In some embodiments, the activation
signal can include an alternating current (AC) signal, and can
optionally further include a direct current (DC) bias signal. Such
a DC bias signal can be varied during measurement of a fluid
property or condition. In some embodiments, multiple frequencies
can be applied and detected, serially or in some cases,
simultaneously applied and detected. In some embodiments, one or
more sensor elements can be activated with a broad-band "white
noise" excitation signal having a wide range of continuous
frequencies. Such an approach allows for detection of differences
from such continuous frequencies. Other activation/excitation
approaches are known in the art.
[0102] Generally, one or more sensor elements activated with an
activation signal in the presence of a intravenous fluid can
generate a response signal which is dependent upon or influenced by
the composition of such intravenous fluid. The response signal can
be conditioned (e.g, amplified, biased, etc.) for example in a
(local or remote) signal conditioning processor (e.g, comprising
one or more signal processing circuits), and can be optionally
transmitted to a (remote or local) signal identification processor.
Calibration signals can be developed and provided corresponding to
known pharmaceuticals or other fluid components, or to a baseline
intravenous fluid (e.g, saline or Ringers' lactate) to aid in
identification of a component of an intravenous fluid. One or more
identifier circuits can be effected to correlate a measured signal
to a specific patient or a specific device. One or more monitoring
circuits can be effected to provide for communication to a human
through a user interface, and/or for comparative monitoring (e.g,
against a selected setpoint). Other circuits and processors can be
used, as described in further detail throughout this specification
and/or as otherwise known in the art.
[0103] Multi-Parametric Approaches
[0104] Generally, and preferably, the apparatus, systems and
methods of the invention are directed to or effective for
identifying one or more components of an intravenous fluid during
administration of the fluid to a subject using a multi-parametric
approach. In such approach, multiple parameters (e.g, multiple
fluid properties such as without limitation refractive index,
electrochemical potential, impedance, admittance, conductivity,
etc.) can be sensed, and the combination of parameters can be
correlated to obtain resolution of components within the fluid.
Hence, an intravenous fluid can be sensed--for example with
multiple sensors (or with a sensor having multiple sensor elements)
and/or with multiplexing of a sensor element to obtain independent
sensing measurements--to generate a multi-parametric profile
characteristic of component identity within the fluid. A
multi-parametric profile can be correlated to determine an identity
of one or more components of the fluid. Such multi-parametric
approaches advantageously provide for improved resolution of
components; therefore such approaches allow for improved ability to
distinguish between different fluid compositions, including for
example the presence or absence of particular active
pharmaceuticals, and/or various concentrations of a particular
active pharmaceutical or other component.
[0105] With further reference to FIG. 4, for example, a sensor can
comprise two or more sensor elements 502, each having a surface
positioned within a cavity (e.g, 540, 340) of a housing (e.g., 530,
330) for contact with the fluid. The housing can be adapted for
fluidic interface with a fluid line assembly of a system for
intravenous delivery of fluid into a patient, or can be defined in
an intravenous infusion device. As shown in FIG. 4, each of the
sensor elements can be passively monitored, and/or can be activated
using an activating circuit, and the response of each of the sensor
elements can be acquired and processed in a processor circuit. The
various responses can be correlated to identify a characteristic
profile of the one or more components in the fluid. See for
example, Examples 2, 3 and 4.
[0106] Generally therefore, and with further reference to FIG. 4,
in preferred embodiments the apparatus, systems and methods of the
invention comprise or use at least two or more sensors or an
integrated assembly comprising two or more sensors (e.g., an
integrated assembly comprising two or more sensor elements, each
sensor element comprising one or more sensing surfaces).
Preferably, such two or more sensors are of different types and/or
having different sensor approaches (e.g., impedance sensor, thermal
sensor, electrical property sensor, optical sensor, etc.) thereby
enabling for orthogonal fluid property measurements. As a
non-limiting example, such two or more sensors can include two or
more of an impedance sensor (e.g, an AC impedance spectroscopy
sensor), a thermal sensor, and/or an optical sensor (e.g., a
refractometry sensor, a transmission sensor, an absorbance sensor,
a spectrometer (including a colorimeter) or, a turbidity sensor).
Preferably, such two or more sensors can be integrated into a
common assembly, such as a common substrate, e.g., as part of a
common sensor subunit, as discussed below in connection with FIG.
6C through FIG. 6G. As a non-limiting example, two or more of an
impedance (e.g., AC impedance) sensor, a thermal (e.g, an
resistance thermal detector) sensor, and an optical (e.g,
refractive index) sensor can be employed in combination.
[0107] In a preferred embodiment, at least one sensor is an
electrical properties sensor such as an impedance sensor.
Independent electrical property (e.g., impedance) measurements can
be derived, for example, from a set of two or more sensor elements
having sensing surfaces defined by electrodes consisting
essentially of different metal materials. Preferred metals include
noble metals and other chemically inert transition metals, such as
without limitation, Au, Pt, Pd, Ag, W, Ti, Ni, Sn, Co and others.
Electrical property measurements such as impedance measurements can
preferably be effected using different pair combinations of three
or more sensor elements. For example, for a sensor comprising
sensor elements A, B and C, three pairs of sensor elements can be
used: an A-B pair, an A-C pair, and a B-C pair, with each of such
pairs defining an independent impedance measurement channel. As
another example, for a sensor comprising five sensor elements A, B,
C, D and E, such five sensor elements can be paired to define ten
independent impedance measurement channels: A-B, A-C, A-D, A-E,
B-C, B-D, B-E, C-D, C-E, and D-E. Such impedance sensor elements
can be activated using alternating current (AC), allowing for
determination of both real and imaginary (complex) impedance
response for each pair of sensor elements. Hence, three sensor
elements can provide for six independent measurement channels at
each applied AC frequency for determining the identity of a
component of the intravenous fluid. Generally, the number of
discrete independent impedance sensor elements can range from 2 to
100, from 2 to 50, from 2 to 20 or from 2 to 10. Pairs of sensor
elements can be activated using multiple (different) frequencies.
If five frequencies are used for activating an impedance sensor
comprising three sensor elements, for example, then the impedance
sensor effectively provides for thirty independent measurement
channels for determining the identity of a component of the
intravenous fluid (three sensor elements.fwdarw.three
channels.times.real and imaginary components.fwdarw.two
channels=six channels per frequency.times.five
frequencies.fwdarw.thirty channels). Generally, the number of
discrete independent frequencies can range from 1 to 100,
preferably from 2 to 100, from 2 to 50, from 2 to 20, from 2 to 10
or from 2 to five or from 2 to 3. Similarly, pairs of sensor
elements can be activated at multiple (different) amplitudes, with
a similar multiplier effect on multi-modal measurements. Generally,
the number of discrete independent amplitudes can range from 1 to
100, preferably from 2 to 100, from 2 to 50, from 2 to 20, from 2
to 10 or from 2 to five or from 2 to 3. Further variations, such as
use of different input signals--sinusoidal, step-wave, pulse,
etc.--can provided for additional independent channels in a
multiparametric context.
[0108] Analogous multiplexing can be effected with other sensors
types (e.g., optical, electrochemical potential, etc.).
[0109] Processing of the signal acquired from each of a plurality
of sensors can be effected in a signal identification processor.
Such processor can comprise signal conditioning circuits for
conditioning one or more signals (e.g., for amplifying, biasing)
prior to or during further processing. Such processor can employ
software or firmware or can include an application specific
integrated circuit (ASIC) effective for and/or adapted to recognize
and distinguish between signals correlating to components of an
intravenous fluid. Such software can comprise pattern recognition
algorithms known in the art. In one relatively simple algorithm,
for example, sensor signals can be processed to recognize the
identity of component substances by measuring produced
deviations--e.g., in various directions by supplying the values for
the expected angles. See for example, Example 4. See also for
example, J. Ross Macdonald, Impedance Spectroscopy Theory,
Experiment, and Applications (2005).
[0110] For example, in embodiments where a set of two or more
sensor elements having sensing surfaces defined by metal electrodes
are exposed to a fluid, and activated by energizing with an AC
voltage or current, the resulting complex current or voltage can
be. measured. When the activating signal is sufficiently small, the
system can respond linearly, and may be modeled in terms of complex
AC impedance or admittance, e.g. having real (x) and imaginary (y)
response components. The measured values of x and y as well as
their relative magnitude change predominantly with the electrical
properties of the fluid flow and fluid-electrode interface, both of
which are heavily affected by the composition of the flow. The
change in these values can be correlated to the nature of the fluid
material and can be used to identify the particular component of
the intravenous fluid. As demonstrated in Example 4, for example,
highly diluted components injected into saline flow can be
identified by such sensors. Generally, a deviation distance from a
data point corresponding to pure saline or Ringer's lactate depends
on both concentration and molecular or ionic composition of the
component, while deviation direction from such data point depends
predominantly on the molecular or ionic composition of the
component. For higher concentrations of the component, both
magnitude and direction of the deviation become
concentration-dependent in unique and distinguishable manner which
is specific to and dependent upon the particular component added to
the saline. Hence, such deviation dependencies enable
identification of components having different compositions or
concentrations. For example, pattern recognition algorithms can be
adapted to recognize substances that are components of an
intravenous fluid. A data signal from sensors can result in
deviations from baseline data corresponding to the background
composition of the intravenous fluid (e.g, saline or Ringer's
lactate), including deviations in magnitudes and/or deviations in
directions, the angles for each of which can be determined as
described above and exemplified in Example 4. In subsequent
operation, such software can compare measured angles determined
from detected data with the values for expected angles
corresponding to certain substances, thereby identifying the
substances. Such pattern recognition algorithms can be
advantageously applied to the differentiation and recognition of
data generated by the sensors in multi-dimensional space.
Additionally, software can be used to determine the cumulative
dosing of a component of a fluid, as well as a projected dosing
over a certain upcoming period of time. For example and without
limitation, once a component is identified, a current cumulative
dosing level can be measured by integrating the signal
corresponding to that component over time during the period defined
from when the signal exceeded a detection threshold to the current
time (e.g., taking into account the sensor sensitivity to
identified substance and the volumetric flow). Projected dosing
levels can extrapolate the component composition and extend the
time period for a defined period.
[0111] Adaptations on such algorithms are known in the art.
Moreover, more elaborate pattern recognition algorithms can be
applied to the differentiation and recognition of curves generated
by the multiparametric sensor system in multi-dimensional space.
See, for example, Sing-Tze Bow, Pattern Recognition and Image
Preprocessing (2002); M. S. Nixon, A. S. Aguado, Feature Extraction
and Image Processing (2002); and D. Maltoni, D. Maio, A. K. Jain,
S. Prabhakar, Handbook of Fingerprint Recognition, 2002. Examples
of other pattern recognition software include without limitation
artificial neural network and fuzzy logic algorithms.
[0112] Preferred Circuit Configurations/Monitoring Approaches
[0113] Generally, and preferably, the apparatus, systems and
methods of the invention are directed to or effective for
identifying one or more components of an intravenous fluid during
administration of the fluid to a subject (e.g., a specific patient,
for example at a hospital, clinic, surgical environment, home
hospice, nursing home, assisted living environment, etc.), where
such subject is positively and specifically identified in
connection with monitoring and administration of the intravenous
fluid. Various embodiments and aspects of the invention can include
approaches for correlating the sensor data (i.e., data (e.g., as
represented by a signal) originating from the sensor--either raw
data or more typically processed data) to a specific subject (e.g.,
patient). For example, the sensor (or apparatus or system
comprising a sensor) can include an identifier circuit for
correlating sensor data to a specific subject. Typically, and
preferably, such identifier circuit may be in communication with
one or more other circuits, including for example circuits for
receiving, processing, storing, displaying or transmitting data,
including data originating from the sensor element, such as a
signal processing circuit or a data retrieval circuit. Such
integrated patient-identification approaches can further enhance
the benefit to patient safety, by reducing the potential for errors
associated with intravenous administration, and especially
intravenous drug administration.
[0114] Generally, and preferably, the apparatus, systems and
methods of the invention are directed to or effective for
identifying one or more components of an intravenous fluid during
administration of the fluid to a subject with a remote and/or
centralized monitoring approach. Although such remote and/or
centralized monitoring approaches can be effected for an individual
subject (e.g, in a home hospice environment), such approaches are
especially advantageous in connection with multi-subject care
environments. For example, different sensor data from one subject
or from several different subjects (in each case, such sensor data
being locally generated and specifically associated with an
intravenous fluid being administered to a particular subject) can
be acquired and/or monitored at a location which is remote
(relative to the patient)--such as a nursing station; preferably
such sensor data can be centrally monitored at such remote
location. In various aspects and embodiments therefore, and with
reference to FIGS. 1B and 1C, FIG. 2, and FIGS. 3A through 3C, for
example sensor data, can be generated in a processor 550 local to
and in communication with a sensor element 502 (e.g., having a
sensing surface in contact with the intravenous fluid), preferably
for each of two or more subjects, and then such locally-generated
sensor data stream(s) can be acquired by a processor 600 remote
from the sensor element 502. Such acquisition can be effected, for
example, via wireless (e.g., Bluetooth.RTM.) or other communication
approaches. The local processor 550 can be in communication with
the sensor element 502, and particularly with a sensing surface 504
thereof, for example through one or more releasable contacts 508
and one or more electrical connections 506. The local processor 550
can be permanently integrated or intermittently integrated
(temporally limited engagement) with the sensing element 502 as
described below.
[0115] The remote processor 600 can comprise one or more circuits
for receiving, processing, storing, displaying or transmitting the
acquired sensor data. The acquired sensor data can be monitored
remotely, including for example at a central monitoring location.
Preferably for example, the monitoring can be done visually by
human interaction with a display and/or can be further enhanced and
effected by various automated approaches. In one such automated
monitoring approach, a monitoring circuit can comprise a data
comparator module for comparing one or more parameters (e.g, data
values) derived from sensor data with one or more parameters (e.g.,
data values) which are prescribed or proscribed for a particular
subject (e.g. patient). Such patient-relevant parameters can be
treatment-centric (e.g., applicable to all such patients undergoing
a particular treatment), including semi-customized
treatment-centric parameters which include a patient-specific data
input (e.g., a patient weight, patient age, etc.) to determine a
treatment-centric parameter, and/or such patient-relevant
parameters can be patient-centric (e.g., wholly customized for a
specific patient). Exemplary non-limiting parameters can include
dosing levels, dosing timing (onset or completion), dosing
frequency, etc. for various and specific active pharmaceutical
agents or other components of an intravenous fluid.
Patient-relevant parameters can be specific for the intravenous
monitoring system effected by the apparatus, systems and methods of
the invention, and/or can be common with (e.g., shared with)
various other systems, such as infusion pump systems (e.g., "smart
pumps"). Advantageously, the monitoring approaches of the
apparatus, systems and methods of the invention can also include
certain notice (e.g., alarm) features--to provide notice to a
caregiver that a specific patient's intravenous fluid delivery
system is operating incongruous with a prescribed or proscribed
treatment, and/or can also include certain corrective action (e.g.,
system control) features--to make, preferably automated, a
corrective action with the intravenous fluid delivery system. For
example, upon determining an inconsistency between corresponding
sensor-data-derived parameter and prescribed or proscribed
patient-relevant parameter, an alarm can sound and/or a control
circuit can activate a control element (e.g., an automated infusion
valve) to make a change in the intravenous administration regime.
Such remote and/or central monitoring approaches can further
enhance the benefit to patient safety, by reducing the potential
for errors associated with intravenous administration, and
especially intravenous drug administration.
[0116] Generally, and preferably, the apparatus, systems and
methods of the invention are directed to or effective for
identifying one or more components of an intravenous fluid during
administration of the fluid to a subject with a sensor that
comprises a processor (e.g, as included within a processor
assembly) which is physically separable from, and intermittently
interfaceable with (e.g., for a finite, operationally effective
period of time) a sensor element (e.g., as included within a
housing assembly). The approach of a temporally-limited engagement
(interlacement) of the processor and the sensor element allows for
regular operation while engaged/interfaced, and allows for physical
separation of sensing function and processing function of a sensor
(at least for some period of time) after or between operations,
with a corresponding separation of physical treatment of the
embodiments which effect such function. For example, and with
reference to FIG. 1B, FIG. 2, and FIG. 3A through 3C, the sensor
element 502 can be physically separated from the processor 550 for
a period of time to allow for sterilizing the sensor element 502
(or a sensing surface 504 thereof) or for disposal and replacement
of a (pre-)sterilized sensor element 502 (or a sensing surface 504
thereof). Such separation also allows for re-use of the processor
550--for example, in connection with a second subsequent subject.
The processor 550 can be engaged for example through a processor
guide 552. Significantly, since processors 550 are generally more
expensive than sensor elements 502 (or sensing surfaces 504
thereof), the re-use of processors 550 in such a temporally-limited
engagement (interfacing) approach provides for efficiency of
capital investment, especially in a multi-subject (e.g., hospital,
surgical, nursing care, etc.) environment.
[0117] In any of the aforementioned approaches and in any of the
aspects and embodiments of the invention, the monitoring system can
include a logging circuit for recording (e.g., storing) sensor data
over time. The logging circuit can be in accessible communication
with a display circuit for intermittent (temporally-limited)
display of sensor data or of a patient-relevant parameter derived
from sensor data. In operation, for example, the logging circuit
can record sensor data without displaying such data (or a
patient-relevant parameter derived therefrom) unless and until
specifically requested (e.g, by a caregiver based on that
caregiver's discretion, and/or by another circuit, such as by the
comparator module of the monitoring circuit when there is an
incongruity between a sensor data parameter and a prescribed or
proscribed patient-relevant parameter) to be displayed. Display,
such as automated display during an abnormal operational event can
help a caregiver understand a situation more quickly and thereby
reduce the risk of a compounded error and improve the corrective
treatment regime. Additionally or alternatively, such display can
be effected ex-post facto to reconstruct facts regarding the
patient experience based on logged sensor data.
[0118] Various preferred schema for circuit configuration and
operation are shown in FIGS. 5A and 5B. With reference to FIG. 5B
illustrated is a high-level schematic diagram showing various
circuits and one arrangement for their interrelationship with local
processor and remote processor, and/or with housing assembly and
processor assembly. FIG. 5A illustrates a block diagram of a
specific preferred circuit configuration for a reader unit
comprising a microcontroller. The circuits of such reader unit can
include, for example, one or more of any of an activation circuit,
a data retrieval circuit, a signal processing circuit, an
identifier circuit, a data acquisition circuit, and/or a monitoring
circuit. Preferably, one or more of any such circuits can be
adapted into a signal conditioning processor and/or a signal
identification processor. Such circuits can be included, for
example, in a processor assembly for intermittently
interfacing/temporally-limited engagement with a sensor element.
Alternatively, some of such circuits could be in a housing
assembly--see for example FIG. 5B. Preferably, with reference again
to FIG. 5A, the reader unit can be programmed when a patient is
admitted for treatment. The reader unit can receive and store the
identification information about the patient either through RF
interface or through I/O interface from the admitting database
information, for example in an identifier circuit. The reader unit
can be physically co-located adjacent to or attached to the
patients, for example as a bracelet, or adhesively attached to a
patient's skin. Once the identification information is received,
and the processor assembly is interfaced with a housing assembly
(described herein), the reader unit can commence broadcasting
identifier information, for example wirelessly via RF interface
such as WiFi or Bluetooth interface, continuously or periodically.
Alternatively the unit can be connected via direct connection (e.g,
electrical wire or optical cable) to a bedside monitoring system,
which can itself send patient identification information through
I/O interface. Along with patient identification information the
unit can also send information regarding the status of the
interface between the processor assembly and the housing assembly
(e.g., whether engaged (operable) or disengaged (non-operable).
Once a patient has received an intravenous line, and when the unit
is engaged for operation, through the interface to the sensing
unit--the reader can verify the connection, energize or activate
the sensors, and sense and transmit data from the sensor element,
and preferably from a local processor to a remote processor
included within a monitoring unit, for example via any suitable
communication approach such as hospital radio frequency port;
alternatively the monitoring can be local, such as via bedside
monitoring equipment.
[0119] Additional preferred schema for an integrated sensor and
circuit configuration are shown in FIGS. 5C through 5E. Generally,
such configuration can include a sensor that comprises (i) an
assembly comprising one or more sensor elements 502, (ii) a
signal-conditioning processor (e.g., optionally included within a
local processor 550 (which can, optionally, be physically separable
from and/or be intermittently interfaceable with the sensor element
502) or included within a remote processor 600), and (iii) a
signal-identification processor, including one or more circuits
adapted for identifying or determining a signal representative of
the identity of one or more components of an intravenous fluid
(e.g., optionally included within a local processor 550 (which can,
optionally, be physically separable from and/or be intermittently
interfaceable with the sensor element 502) or included within a
remote processor 600). With reference to FIG. 5C for example, in
one such preferred subembodiment, each of the assembly comprising
the one or more sensor elements 502, the signal-conditioning
processor (550 or 600), and the signal-identification processor
(550 or 600) are each physically separate components. In an
alternative of such preferred subembodiment, represented
schematically in FIG. 5D, the assembly comprising the one or more
sensor elements 502 is physically separate from an integrated
assembly comprising the signal-conditioning processor (550 or 600)
and the signal-identification processor (550 or 600). In another
subembodiment shown in FIG. 5E, each of the one or more sensor
elements 502, the signal-conditioning processor (550 or 600), and
the signal-identification processor (550 or 600) are integrated
into a common (integrated) assembly. Such various approaches for
configuring the sensor elements, the signal-conditioning processor
and the signal-identification processor are preferred, an can be
generally used with any aspects, embodiments and approaches
described herein.
[0120] FIG. 6(A, B) illustrate schematic representations of various
sensors, including an optic fiber refractive index sensor (FIG. 6A)
and an electrical property sensor (e.g., which can be configured
and employed, for example, as an impedance sensor or for example,
as an electrochemical potential sensor) (FIG. 6B). Such sensors and
others described herein are known in the art. Briefly, with
reference to FIG. 6A, an optical sensor can comprise a fiber optic,
such as a flexible fiber optic formed in a U-shape, and having an
optical entrance 501, a sensor element 502 defined by the curved
region of fiber optic exposed to the intravenous fluid, and an
optical exit 503 into a detector. In operation, a light can be
admitted to the fiber optic, guided to the sensor element 502 and
exposed to an intravenous fluid in communication with the sensor
element 502. Variations in intensity of the light coupled from the
entrance to exit are proportional to the refractive index of the
fluid. The index of refraction can be fluid-composition variable,
thereby providing a parameter for determining the identity of the
fluid composition. See, for example, Examples 1, 2 and 3. Referring
further to FIG. 6B, an electrical property sensor (e.g, impedance
sensor, electrochemical potential sensor, etc.) can comprise a
plurality of sensor elements 502a, 502b, 502c. For example, each of
the sensor elements can comprise a sensing surface consisting of a
material such as a metal, with the sensing surface of each such
sensor element being the same material, or in some embodiments a
different material, such as a different metal. Preferably, metal
materials are chemically inert within the fluid environment.
Preferred metals include noble metals and other chemically inert
transition metals, such as without limitation, Au, Pt, Pd, Ag, W,
Ti, Ni, Sn, Co and others. Each of the sensor elements 502a, 502b,
502c are in electrical communication with dedicated corresponding
contacts 508a, 508b, 508c, respectively, for example, through
dedicated corresponding electrical connectors 506a, 506b, 506c. The
sensor elements 502, contacts 508 and electrical connectors 506 can
be formed or supported on a common substrate, such as common
microfabrication substrate. In operation, the electrical property
(e.g, impedance or electrochemical potential) associated with each
of the sensor elements 502a, 502b, 502c can be measured
independently and simultaneously, proving for three independent
real-time channels for multiparametric characterization of a
component within an intravenous fluid.
[0121] A preferred sensor embodiment can comprise an integrated
assembly comprising two or more sensor elements, such as impedance
sensor elements, thermal sensor elements and/or refractive index
sensor elements. With reference to FIG. 6C through FIG. 6G, for
example, an integrated sensor assembly can comprise one or more
substrates, such as a first sensor element substrate 520 and
comprising two or more sensor elements. The first sensor element
substrate 520 can have a first (top as shown) surface 521 and a
second (bottom as shown) surface 522. As depicted, and with
specific reference to FIG. 6C, FIG. 6D and FIG. 6E (showing detail
of tip portion of the sensor element substrate of FIG. 6D) for
example, the first substrate can comprise impedance sensor elements
502b, 502c, 502d, and also thermal sensor elements 502a, 502e. The
impedance sensor elements 502b, 502c, 502d, and the thermal sensor
elements 502a, 502e, can each comprise a sensing surface defined by
a metal electrode. The metal electrode preferably consists
essentially of a chemically inert, conductive material. Metals or
metal compositions comprising noble metals and other transition
metals are preferred. Examples include Au, Pt, Pd, Ag, W, Ti, Ni,
Sn, Co and others. Preferably, the impedance sensor elements 502b,
502c, 502d each comprise a sensing surface defined by different
types of metals (e.g., where 502b, 502c, 502d have a sensing
surface defined by electrodes consisting essentially of Au, Pt, Pd,
respectively). The thermal sensor elements 502a, 502e can each
comprise a sensing surface defined by the same type of metal (e.g.,
Au). Electrical connectors 506b, 506c, 506d provide a conductive
path (for signal communication) between impedance sensor elements
502b, 502c, 502d and corresponding contacts 508b, 508c, 508d,
respectively. Similarly, electrical connectors 506a, 506e, provide
a conductive path (for signal communication) between thermal sensor
elements 502a, 502e, and corresponding contacts 508a, 508e,
respectively. As depicted, and with specific reference to FIG. 6C,
the first substrate 520 can also comprise a refractive index sensor
element 502' integrally configured within the body of the first
substrate 520. As shown for example, such refractive index sensor
element can comprise an optically transparent region of the
substrate 520 defining a wave guide 524, 525, 526, and further
defined by a region 528 of the substrate which is optically less
transparent or substantially non-transparent. With specific
reference to FIGS. 6F and 6G, the integrated sensor assembly can
further comprise a second capping substrate 530 having a first (top
as shown) surface 531 and a second (bottom as shown) surface 532.
The second capping substrate 530 can be adapted with an aperture
situated over and providing for fluid access to sensor elements
502a, 502b, 502c, 502d, 502e, and being further adapted with
apertures situated over and providing electrical access to each of
the contacts 508a, 508b, 508c, 508d, 508e. In the configured sensor
assembly, the first (top) surface 521 of the first sensor element
substrate 520 can be capped/sealed by integral contact with the
second (bottom) surface 532 of the second capping substrate 530.
Fabrication of such integrated subassembly can be facilitated by
alignment pads 535 on the first surface 521 of the first substrate
520 and spatially corresponding apertures in the second capping
substrate 530. As shown in FIG. 6F and FIG. 6G, the integrated
sensor assembly can further comprise a functional communication
port 536, such as a USB port, providing independent electrical
communication with each of the contacts 508a, 508b, 508c, 508d,
508e.
[0122] In operation, with reference to FIGS. 6C and 6G, an
intravenous fluid being measured can be in fluid communication with
the curved tip portion of the integrated sensor assembly. The
impedance sensor elements 502b, 502c, 502d can be activated using
an activation circuit in electrical communication with these sensor
elements through communication port 536, contacts 508b, 508c, 508d
and electrical connectors 506b, 506c, 506d, respectively. A
responsive signal can be received from each of these sensor
elements by a data retrieval circuit in electrical communication
therewith through the same independent communication paths. Three
independent channels can be configured for impedance
measurements--using different pairs of impedance sensor elements in
combination--namely: (i) 506b-506c; (ii) 506c-506d; and (iii)
506b-506d. Each of such pairs of sensor elements can be activated
using alternating current (AC), allowing for determination of both
real and imaginary (complex) impedance response for each pair of
sensor elements. In this configuration therefore, the impedance
sensor can effectively provide for six independent measurement
channels at each applied AC frequency for determining the identity
of a component of the intravenous fluid. These pairs of sensor
elements can be activated using multiple frequencies. If five
frequencies are used for impedance sensor element activation, for
example, then the impedance sensor effectively provides for thirty
independent measurement channels for determining the identity of a
component of the intravenous fluid. The thermal sensor elements
502a, 502e can be variously configured, for example for measuring
temperature and or flow (e.g., as a thermal flow anemometer). In
one embodiment for example, thermal sensor elements 502a, 502e are
configured as a resistance temperature detector (RTD), and can be
activated using an activation circuit in electrical communication
with these sensor elements through communication port 536, contacts
508a, 508e and electrical connectors 506a, 506e, respectively. A
responsive signal can be received from each of these sensor
elements by a data retrieval circuit in electrical communication
therewith through the same independent communication paths. The
refractive index sensor can be used simultaneously and in
combination with the impedance sensor elements 502b, 502c, 502d,
and the thermal sensor elements 502a, 502e. With reference to FIG.
6C, for example, incident light (e.g, from an infrared light
emitting diode (LED) source) can be admitted through an inlet end
into a first section 524 of the wave guide, and allowed to interact
with the intravenous fluid in a second section 525 of the wave
guide which defines the refractive index sensor element 502'. The
efficiency of light coupled through the waveguide is affected by
refractive index of a fluid into which the waveguide is immersed;
the resulting signal is proportional to the fluid refractive index.
Light can be retrieved through a third section 526 of the wave
guide at an outlet end of the wave guide into a photo-sensitive
detector (for example into an infrared phototransistor) configured
for detecting the output light. A multimeter (e.g., a Keithley
Model 2100 Multimeter) can measure voltage output of the
photo-sensitive detector, and such output signal can be
communicated to a data retrieval circuit. Generally, each of the
signals received from the impedance sensor elements, thermal sensor
elements, or refractive index sensor element can be independently
conditioned (e.g., amplified, biased, etc.) in signal processing
circuit within a (e.g., local or remote) signal conditioning
processor, and can processed in a signal identification processor
(e.g., local or remote), for example using multiparametric
analysis, to identify a component of the intravenous fluid. The
identified component can be correlated to a specific patient
through use of an identifier circuit, as described above.
EXAMPLES
Example 1
General Methods for Identifying a Components Typical of an
Intravenous Fluid
[0123] In this example, materials were obtained from Sigma Aldrich
and dissolved or diluted with 0.9% saline to reach the desired
concentrations. Solutions of insulin, heparin and potassium
chloride were prepared at concentrations comparable to typical
bolus doses used in medical settings. All experiments were carried
out using prepared solutions contained in 20 ml glass vials.
Samples were measured by dipping admittance and optical sensor
probes into each vial such that the active area of each probe was
fully submerged in the solution to be tested. The response of each
sensor to air and tap water were also measured.
[0124] The admittance signal is measured using a probe constructed
with noble metal pads embedded in a polymer substrate. All
measurements were performed at a frequency of 100 kHz. An Agilent
Model 4395A network analyzer was utilized for measuring the
admittance probe.
[0125] The optical sensor is constructed from a section of optic
fiber with an infrared LED fed into one end and an infrared
phototransistor detecting the output at the opposite end. The fiber
jacket is removed along a section of its length and this section is
bent into a curve. In this configuration, the efficiency of light
coupled through the fiber is affected by refractive index of a
fluid into which it is immersed and the resulting signal is
inversely proportional to the fluid refractive index. A Keithley
Model 2100 Multimeter was used to measure the voltage output of the
optical sensor phototransistor detector and all data is recorded
using a PC.
Example 2
Identification of Various Active Pharmaceutical Agents and other
Components Typical in an Intravenous Fluid
[0126] The sensor configuration and method described in Example 1
was used to identify components typically included in intravenous
fluids, including pharmaceutical agents and other components.
Specifically, the methods were applied to identify potassium
chloride (KCl), sodium chloride (saline) (NaCl), heparin, water,
insulin and air using admittance and refractive index sensors.
[0127] The results are summarized in Table 3, and shown graphically
in FIGS. 7(A-C) for measurements of admittance, real portion (FIG.
7A), admittance, imaginary portion (FIG. 7B), optical refractive
index (FIG. 7C).
[0128] A multi-parametric representation of such measurements is
shown in FIG. 7D. As observed from these results, the
multi-parametric analysis and data provide improved resolution of
the various components of the intravenous fluid, and therefore
allow for a more robust approach for distinguishable measurement
thereof. The multi-parametric profile can be characteristic of the
fluid component.
TABLE-US-00003 TABLE 3 Sensor Responses for Various Components
Material Admittance Admittance* Optical Signal KCL 64.310 55.094
2.084 Saline 25.368 12.800 2.168 Heparin 14.200 3.775 2.144 Water
0.481 0.129 2.171 Insulin 5.857 1.339 2.166 Air 0.010 0.141 2.210
Note 1: The optical signal is inversely proportional to refractive
index. Note 2: Admittance denotes the real admittance. Note 3:
Admittance* denotes the imaginary (complex) admittance.
Example 3
Identification of Component Typical of Intravenous Fluid in
Dilution Series
[0129] A set of dilution series experiments were conducted, in
which concentrated samples of heparain, insulin and potassium
chloride were each diluted by half concentration a total of three
times to give concentrations of 1, 1/2, 1/4, and 1/8 of a typical
bolus dose and each one measured using the admittance and optical
sensors described in Example 1 according to the approach described
in Example 1.
[0130] The data for each dilution series of heparin, insulin and
potassium chloride are shown in Tables 4A, 4B and 4C, respectively.
Concentration is relative dilution. Admitt.=Admittance (real
portion). Admitt.*=Admittance (imaginary portion).
[0131] These results are also shown graphically in FIGS. 8(A-C) for
measurements of admittance, real portion (FIG. 8A), admittance,
imaginary portion (FIG. 8B), optical refractive index (FIG. 8C). A
multi-parametric representation of such measurements is shown in
FIG. 8D; the multi-parametric analysis and data demonstrate
resolution of these various components at different
concentrations.
Example 4
Identification of Intravenous Fluid Components with Multi-Channel
Impedance Sensor
[0132] A set of experiments were conducted using a multi-channel
impedance sensor comprising two sensor elements. The two sensor
elements each comprised a sensing surface defined by circular gold
electrodes, 0.32 mm diameter, situated coplanar and at a distance
of 0.75 mm from each other on a wall of a non-conductive flow path.
An intravenous fluid consisting of 0.9% saline was provided in an
infusion bag set on hanger. A fluid line assembly comprising an
intravenous dripper was inserted, and flow from the infusion bag
was initiated at a typical infusion rate .about.120 cc/hr). The
fluid line assembly comprised an injection port. The aforementioned
gold electrode sensor elements were provided downstream from the
injection port.
[0133] In this example, the sensor was used to measure the real and
imaginary impedance of saline (0.90) flowing through the fluid line
assembly at steady state. A bolus (1 ml) of saline-diluted
potassium chloride (10 mg/ml) was injected into the flowing saline,
and detected by the sensor. Independently and subsequently, a bolus
(1 ml) of saline-diluted magnesium sulfate (40 mg/ml) was injected
into the flowing saline and detected by the sensor. Independently
and subsequently, a bolus of approximately 1 ml of plain deionized
water was injected into the flowing saline, and detected by the
sensor.
[0134] In each case, both in-phase and out-of-phase components of
the current through the sensor were continuously recorded and
plotted by the system. The real, in-phase component of the current
was plotted along the X-axis and the imaginary, out-of-phase of the
current was plotted along the Y-axis of the chart. Briefly, a 100
KHz AC voltage of 8 mV amplitude was applied across the electrodes
in series with a 50 Ohm resistor, and the voltage drop across the
resistor was measured using a Stanford Research Model SR830 lock-in
amplifier. A microprocessor (a personal computer) was connected to
the lock-in amplifier via RS232 interface with software recording
the complex voltage read by the lock-in amplifier at a data
sampling rate of approximately twice per second. The data was
plotted with the real part of the measured voltage value along
X-axis and the imaginary part--along Y-axis. In our experiments, an
average x.sub.0+iy.sub.0 and standard deviation .tau. were
determined, accounting for naturally occurring noise. A measured
voltage value x+iy deviating from the average value by
|.DELTA.x+i.DELTA.y|>6.sigma. in any direction on the XY chart
is a statistically significant indication of a change in the fluid.
In this case, arg(.DELTA.x+.DELTA.y) defines the angular direction
of the deviation vector. Two deviations
.DELTA.x.sub.1+.DELTA..sub.y1 and .DELTA.x.sub.2+i.DELTA.y.sub.2
are statistically distinguishable if
|.DELTA.x.sub.1+.DELTA.y.sub.1|6.sigma. and
|.DELTA.x.sub.2+i.DELTA.y.sub.2|>6.sigma. and
|.DELTA.x.sub.1-.DELTA.x.sub.2+i(.DELTA.y.sub.1-.DELTA.y.sub.2)|>6.sig-
ma.. The latter inequality defines the relationship between the
magnitude of the deviations and the angle between them for the
deviations to be distinguishable from each other.
[0135] The values determined from the sensor in flowing saline
resulted in substantially overlapping data points, as shown on the
plot included as FIG. 9A.
[0136] The bolus of saline-diluted potassium chloride (KCl)
injected into the saline flow through the injection port was
detected by the sensor, resulting in a 2-dimensional characteristic
signature for the KCl component. (See FIG. 9A). Multiple injections
of potassium chloride (KCl) resulted in distinct substantially
overlapping curves, as shown. Without being bound by theory not
expressly recited in the claims, following injection of the
saline-diluted potassium chloride into the flow as a bolus dose,
the leading "front" edge of the flow profile for the bolus reaches
the vicinity of the electrodes, and the complex current deviates
from its average value in pure saline and returns back when
trailing "back" edge of the flow profile for the bolus passes the
vicinity of the electrodes, thereby producing the characteristic
signature. One can observe that the leading edge of the potassium
chloride injection produces deviation from the data point
representing the saline and that such deviation is nearly linear
and at a distance far greater than the 6.sigma. threshold of
detection, thereby allowing for accurate determination of the
direction of the deviation vector. For example, one can effect a
linear regression of the measurement points from the 6.sigma.
threshold of detection to the distance where residuals start
exceeding 6.sigma.. For further results, one can also calculate an
angle between X-axis and the directional vector of the deviation
based on regression coefficients, which angle was found to be about
74.4.degree. for potassium chloride under the conditions of this
experiment.
[0137] The bolus of saline-diluted magnesium sulfate (MgSO4)
injected into the saline flow through the injection port was also
detected by the sensor, resulting in a 2-dimensional characteristic
signature of the MgSO4 component--which was readily distinguishable
from the signature for the KCl component. (See FIG. 9A) Multiple
injections of magnesium sulfate (MgSO4) resulted in distinct
substantially overlapping curves, as shown. Without being bound by
theory not expressly recited in the claims, the saline-diluted
magnesium sulfate results in a unique characteristic signature
which was differentiated from the data resulting from the potassium
chloride. As seen in FIG. 9A, the deviation from the saline point
is relatively more vertical and of a relatively smaller magnitude
as compared to the deviation of potassium chloride. The angle of
the initial deviation, calculated as explained above, was found to
be 85.6.degree. for the magnesium sulfate under the conditions of
this experiment.
[0138] The bolus of deionized water injected into the saline flow
through the injection port was likewise detected by the sensor,
resulting in a 2-dimensional characteristic signature of the
H.sub.2O component--which was readily distinguishable from both the
signature for the KCl component and the signature of the MgSO4
component, deviating in nearly the opposite direction therefrom.
(See FIG. 9B) The angle of initial deviation for the water
component as detected by the sensor was -118.2.degree..
[0139] In each case, the statistical uncertainty for the determined
angles was estimated from the residuals of the linear regression
used to calculate coefficients determining the angles, and for all
three substances--potassium chloride, magnesium sulfide and
water--was found to be .+-.0.62.degree..
[0140] These data demonstrate that highly diluted components
injected into saline flow can be identified. Generally, deviation
distance from a data point corresponding to pure saline depends on
both concentration and molecular or ionic composition of the
component, while deviation direction from such data point depends
predominantly on the molecular or ionic composition of the
component. For higher concentrations of the component, both
magnitude and direction of the deviation become
concentration-dependent in unique and distinguishable manner which
is specific to and dependent upon the particular component added to
the saline. Hence, such deviation dependencies enable
identification of components having different compositions or
concentrations.
[0141] Software can be used to identify potassium chloride,
magnesium sulfide and water components within an intravenous saline
fluid, based on the results of the aforedescribed experimental
data. In one approach, for example, pattern recognition software
can continuously observe voltage data derived from the sensor and
check whether the value exceeds the 6.sigma. threshold. Once the
threshold is exceeded, the software can indicate that a different
substance is likely present in the flow and can start a linear
regression on the consecutively measured points, checking whether
residuals exceed the 6.sigma. threshold. The algorithm may, at that
point, conclude that the linear section of the deviation curve was
over, and may calculate a directional vector for the data set being
reduced. The directional vector can be compared to vector values
previously determined for specific components (e.g,
pharmaceuticals) of interest. More specifically, for example, such
analysis can be effected in terms of angles. For example, when the
detected deviation corresponds to an angle of
74.4.+-.0.62.degree.--the software can identify the injected bolus
as likely being potassium chloride. Similarly, for example, if the
detected deviation corresponds to an angle of 85.6.+-.0.62.degree.
or an angle of -118.2.+-.0.62.degree., the software can identify
injected substance as magnesium sulfate or deionized water,
respectively. If the detected deviation angle does not correspond
to angle for any known substances under the conditions of
measurement, then the algorithm can report a detected unknown
substance. Once a component is identified, a current cumulative
dosing level can be measured by integrating either x or y or
|.DELTA.x+i.DELTA.y| over time during the period defined from when
the signal exceeded the detection threshold to the current time
(e.g., taking into account the sensor sensitivity to identified
substance and the volumetric flow).
[0142] Such pattern recognition algorithm can also be adapted to
recognize other substances that are components of an intravenous
fluid. Such substances will produce deviations in various
directions, the angles for each of which can be determined as
described above. In subsequent operation, such software can compare
measured angles determined from detected data with the values for
expected angles corresponding to certain substances, thereby
identifying the substances. More elaborate pattern recognition
algorithms can also be applied to the differentiation and
recognition of data generated by the sensors in multi-dimensional
space, as described in the specification.
[0143] The various examples described herein are representative of,
and not to be considered limiting of the inventions disclosed and
claimed herein.
TABLE-US-00004 TABLE 4A Heparin Dilution Series Heparin Relative
Conc. Optic Admitt. Admitt.* 1.000 2.1284 33.68978 14.12309 0.504
2.1390 29.85923 13.55784 0.248 2.1455 29.57476 13.1181 0.124 2.1432
26.91454 13.59039 0.000 2.1434 23.98381 10.90867
TABLE-US-00005 TABLE 4B Insulin Dilution Series Insulin Relative
Conc. Optic Admitt. Admitt.* 1.000 2.1313 6.59935 1.33295 0.503
2.1402 10.9246 3.14695 0.240 2.1424 17.6113 7.30539 0.126 2.1434
21.2221 10.3648 0.000 2.1434 23.9838 10.9087
TABLE-US-00006 TABLE 4C Potassium Chloride Dilution Series KCL
Relative Conc Optic Admitt. Admitt.* 1.000 2.0889 66.51804 57.43262
0.496 2.1258 54.16412 39.15326 0.221 2.1360 42.24291 27.72464 0.123
2.1420 36.42675 20.27508 0.000 2.1434 23.98381 10.90867
* * * * *
References